TSS:Rfhg 114505.1

Basic information about the TSS

---

TSS ID: rfhg_114505.1 TSS ID(Version3): hg_96492.1 hg_96493.1 hg_96491.1 Species: human Chr: chr9		Start: 33817675 End: 33817886 Strand: +
Source datasets	FANTOM5|PRJNA4843412|PRJDB5282|DRA013844
Protocol	CAGE|NETCAGE|C1CAGE
TSS cluster detected*	4

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D4186462,EH38E2690758)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AJ240087:0 CR457233:0 GeneID: 54926 HGNC/MGI_ID: HGNC:19907 UniProt_ID: Nearer transcript ids and distances: AK225880:-96 BC004862:-98 AK000426:-108 BC047584:-347 view more...

Gene_name: ubiquitin conjugating enzyme E2 R2 Gene_symbol: UBE2R2 Gene_synonyms: CDC34B FLJ20419 MGC10481 UBC3B Gene_source: HGNC:19907

TATA-Box annotation

---

Distance to TSS:	620
Nearest PromoterID:	NM_017811
Entrez ID:	54926
Nearest Unigene:	Hs.643648
Nearest Refseq:	NM_017811
Nearest Ensembl:	ENSG00000107341
Gene Name:	ubiquitin conjugating enzyme E2 R2
Gene Alias:	CDC34B|E2-CDC34B|UBC3B
Gene Type:	protein-coding
CpG%:	0.099526
GC%:	0.726415
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@UBE2R2 p2@UBE2R2 p3@UBE2R2 p4@UBE2R2 p5@UBE2R2 p6@UBE2R2 p7@UBE2R2 p8@UBE2R2 p9@UBE2R2 p10@UBE2R2
Sample		p1@UBE2R2	p2@UBE2R2	p3@UBE2R2	p4@UBE2R2	p5@UBE2R2	p6@UBE2R2	p7@UBE2R2	p8@UBE2R2	p9@UBE2R2	p10@UBE2R2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	37.21	5.65	3.31	4.48	0.58	1.75	0.39	1.17	0.39	0.78
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	38.24	6.27	5.06	1.82	0.40	1.62	0.00	0.00	0.00	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	35.49	4.82	3.67	2.31	0.39	2.31	0.39	0.19	0.00	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	30.56	4.37	1.66	2.29	0.42	0.62	0.00	0.62	0.21	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	36.22	5.17	3.37	2.25	0.45	0.45	0.22	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	30.82	3.29	1.94	1.55	0.78	0.78	0.00	0.58	0.19	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	38.57	9.80	3.70	3.05	0.22	1.31	0.00	0.22	0.22	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	29.07	6.54	2.18	2.91	0.97	1.70	0.24	0.00	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	30.56	8.33	3.63	2.14	0.21	1.71	0.00	0.43	0.00	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	24.34	5.80	0.58	1.74	0.58	0.58	0.00	0.00	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	24.66	7.28	0.81	1.62	0.40	2.43	1.21	0.81	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	20.73	10.16	2.85	2.03	0.81	2.85	0.00	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	75.12	6.61	1.93	2.74	1.77	2.10	1.13	0.64	0.16	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	47.36	7.52	1.35	0.45	1.80	0.60	0.60	1.20	0.15	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	60.60	5.71	1.76	2.63	1.32	1.32	0.66	0.66	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	64.88	6.79	1.51	2.01	3.02	2.01	1.26	1.26	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	55.04	6.99	0.87	0.66	1.09	1.53	0.22	0.22	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	57.79	6.33	0.42	2.11	2.95	0.42	0.84	1.27	0.42	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	47.45	9.06	2.13	1.07	1.07	0.00	1.60	1.60	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	51.60	8.58	2.11	1.81	1.65	1.20	0.45	0.45	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	53.46	7.35	0.94	2.14	1.20	1.74	0.40	0.94	0.40	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	52.13	7.25	0.86	2.24	1.90	1.04	0.17	1.55	0.35	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	51.19	5.82	1.81	1.68	2.20	1.94	1.03	1.42	0.13	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	54.84	8.01	1.94	1.46	1.46	0.97	0.49	0.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	60.11	6.97	1.03	1.81	1.81	1.81	0.52	0.26	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	66.15	7.28	1.90	1.27	2.53	1.58	0.32	1.27	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	47.25	7.14	2.20	1.10	3.30	0.00	0.55	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	54.46	7.31	0.94	2.36	1.89	0.71	1.41	0.71	0.24	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	48.78	6.95	1.29	2.42	1.29	1.13	0.32	0.65	0.16	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	47.23	6.15	1.81	1.99	0.72	0.72	0.72	0.36	0.00	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	34.33	5.23	0.84	2.30	1.88	1.47	1.05	0.84	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	37.12	6.06	0.78	0.98	2.15	1.37	0.59	0.78	0.59	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	36.72	5.70	0.42	1.06	2.11	1.27	0.21	0.84	0.84	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	36.78	6.93	1.15	0.99	0.99	0.49	0.49	1.48	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	36.09	5.05	0.93	1.31	1.31	1.31	0.00	1.12	0.19	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	43.12	4.60	1.72	0.38	2.68	1.92	0.38	0.96	0.38	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	47.62	6.95	1.02	1.43	2.86	1.23	1.02	0.41	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	40.70	8.46	1.01	1.01	1.01	0.40	0.81	1.01	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	42.95	8.91	1.35	1.35	1.89	1.08	0.27	0.27	0.27	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	38.17	6.00	1.20	0.48	1.92	0.24	0.48	0.24	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	37.88	4.47	0.71	1.88	1.88	0.71	1.18	0.94	0.24	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	36.31	4.98	0.44	1.61	0.73	0.88	0.29	1.02	0.44	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	42.18	4.43	1.27	1.48	3.16	0.63	0.84	1.27	0.21	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	40.39	6.12	0.70	1.40	2.45	1.05	0.35	1.75	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	39.55	6.42	1.61	1.61	2.41	0.80	0.80	0.60	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	42.34	5.35	0.70	1.86	3.02	1.16	0.47	1.63	0.00	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	40.06	5.76	1.20	2.64	2.40	1.68	0.72	1.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	46.50	6.56	1.19	1.79	1.19	0.60	1.49	1.19	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	35.67	7.90	1.44	2.87	3.35	0.96	0.48	0.96	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	36.80	6.87	0.20	1.82	2.02	0.61	0.81	0.20	0.61	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	26.44	4.10	0.20	2.25	2.87	0.82	1.43	2.25	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	30.24	5.11	0.89	1.78	2.22	1.33	1.78	0.89	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	97.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	18.10	5.68	0.00	1.06	1.42	1.06	0.71	1.42	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	21.54	4.31	0.99	1.33	3.31	0.99	0.66	1.33	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	55.37	5.87	0.84	0.84	0.00	0.84	1.68	2.52	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	24.80	4.59	0.46	1.38	0.92	1.38	0.92	0.92	0.00	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	24.96	6.16	1.30	0.97	1.30	0.32	0.97	1.94	0.32	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	23.45	3.85	0.00	0.64	1.93	1.93	0.96	0.96	0.64	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	32.69	6.29	0.63	0.31	1.89	0.94	1.89	1.26	0.63	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	13.40	4.94	0.00	0.71	0.71	0.00	0.71	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	15.70	7.29	0.56	0.00	4.49	0.56	1.12	1.68	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	55.73	1.59	0.80	2.39	0.00	2.39	0.00	0.80	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	31.94	3.06	0.34	0.34	1.36	0.34	1.02	1.70	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	23.72	6.17	0.97	1.30	2.92	0.32	1.30	1.30	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	18.81	4.61	0.00	1.42	1.42	1.06	2.48	1.06	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	110.56	7.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	21.45	6.83	0.49	1.95	0.98	1.46	0.49	0.98	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	18.35	5.45	0.50	0.99	2.48	0.00	0.50	0.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	19.70	7.51	0.47	0.47	0.47	0.47	0.47	0.94	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	30.47	1.32	0.00	0.00	0.99	0.99	0.33	1.66	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	21.34	5.26	0.00	0.93	0.93	0.93	0.93	2.78	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	26.29	7.34	0.92	0.61	0.61	0.61	0.61	1.22	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	32.63	6.49	0.79	1.11	2.22	1.11	0.95	0.63	0.16	0.48
Adipocyte - breast, donor2	11327-117E4	44.76	5.94	0.64	1.44	1.76	1.28	0.80	1.93	0.32	0.32
Adipocyte - omental, donor1	11473-119C6	37.15	6.11	0.25	1.02	1.78	1.78	0.76	0.51	0.89	1.02
Adipocyte - omental, donor2	11474-119C7	31.39	7.47	0.75	0.00	2.24	0.75	0.75	0.00	1.49	0.00
Adipocyte - omental, donor3	11475-119C8	38.52	5.69	1.67	1.67	3.68	1.34	0.67	0.67	0.33	1.00
Adipocyte - perirenal, donor1	11476-119C9	31.26	1.91	0.00	1.28	0.00	1.91	1.28	0.00	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	41.78	5.50	0.00	3.30	2.20	3.30	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	29.36	5.42	0.90	2.71	0.45	0.45	0.45	0.00	0.00	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	60.65	7.82	1.04	1.91	1.04	0.35	0.87	1.04	0.35	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	46.35	17.01	1.76	2.74	3.72	1.17	0.78	0.98	0.20	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	37.58	10.04	1.54	2.32	2.06	0.26	0.51	0.51	0.00	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	41.82	10.04	1.95	1.67	3.07	0.28	1.12	1.12	0.28	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	39.38	14.11	0.59	4.11	4.70	1.18	0.59	0.59	0.00	1.76
Adipocyte differentiation, day08, donor1	13020-139D5	57.67	9.33	1.37	3.14	2.73	1.13	0.97	0.32	0.16	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	51.64	10.65	0.65	1.61	2.58	1.29	0.32	0.97	0.00	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	38.39	4.27	0.53	2.67	2.67	0.53	0.00	1.60	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	40.06	8.35	1.67	2.23	4.45	1.11	1.11	0.00	0.56	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	30.36	4.99	1.25	2.08	4.16	0.00	0.83	0.83	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	42.45	9.54	0.50	2.26	1.26	1.00	0.50	1.76	0.00	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	34.36	6.22	1.31	0.33	2.62	0.98	0.33	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	35.93	6.39	0.91	1.52	4.87	1.22	0.30	0.00	0.30	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	50.39	13.04	1.99	1.10	1.99	1.99	0.66	0.44	0.22	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	43.03	15.78	0.00	0.36	2.51	1.43	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	38.34	4.79	2.40	1.20	1.20	3.59	0.00	1.20	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	50.73	12.05	1.44	0.36	1.62	2.16	0.72	0.54	0.72	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	63.59	15.06	1.67	1.67	1.67	1.67	0.00	3.35	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	49.72	8.83	0.00	1.03	2.26	0.62	0.82	0.82	0.62	0.21
Anulus Pulposus Cell, donor1	11248-116E6	58.81	10.18	2.06	2.98	1.95	1.26	1.26	1.37	0.11	0.11
Anulus Pulposus Cell, donor2	11463-119B5	50.94	8.57	1.47	0.98	1.22	1.96	0.73	0.98	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	22.91	5.39	0.90	0.90	0.90	0.90	0.90	1.80	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	30.82	6.08	1.74	1.30	0.43	0.00	0.43	1.74	0.00	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	0.00	0.00	0.00	2.14	0.00	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	26.01	5.38	0.30	1.20	1.49	0.60	1.79	1.79	0.60	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	32.88	6.32	1.26	1.26	0.00	0.00	0.00	5.06	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	21.12	4.62	0.00	0.66	1.32	0.00	0.66	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	21.44	4.87	0.65	0.32	0.32	0.65	0.97	0.32	0.65	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	32.04	7.28	0.49	0.97	1.94	0.49	0.00	0.49	0.49	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	20.79	4.16	1.19	0.00	1.19	1.19	1.19	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	24.48	5.27	2.64	0.75	0.75	1.13	1.13	1.88	0.38	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	25.40	7.26	0.73	0.00	3.63	0.73	2.18	0.00	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	18.81	5.02	0.00	0.00	1.25	1.25	2.51	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	32.62	7.25	1.15	0.82	1.65	0.49	0.82	0.00	0.00	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	25.93	10.92	0.00	0.00	1.36	0.00	0.00	0.00	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	21.56	6.18	0.15	0.60	1.51	0.60	1.06	0.45	0.00	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	19.82	5.89	2.14	0.00	1.61	0.54	2.14	0.00	1.07	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	31.55	6.05	1.13	0.76	1.70	0.38	0.76	0.57	0.00	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	26.73	5.08	1.07	0.80	1.34	0.27	0.53	0.80	0.27	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	28.29	6.83	0.00	0.00	0.98	1.95	0.00	2.93	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	28.53	5.81	1.33	1.16	0.83	0.66	0.83	0.33	0.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	15.61	7.20	0.00	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	24.78	24.78	0.00	0.00	3.54	3.54	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	30.53	8.58	1.89	0.51	1.20	1.20	0.69	1.03	0.00	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	4.19	0.00	0.00	0.00	0.00	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	18.93	7.77	0.00	0.97	1.94	0.49	0.97	0.49	0.49	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	33.01	4.55	0.76	0.76	0.76	0.38	0.76	0.00	0.76	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	19.38	2.42	0.00	2.42	2.42	1.21	0.00	2.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	30.21	10.83	1.14	1.71	0.00	0.00	1.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	28.65	8.12	0.86	0.86	1.71	0.00	1.07	1.07	0.43	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	22.97	4.39	0.00	0.77	1.81	0.77	0.00	0.77	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	22.52	6.10	0.47	0.00	0.47	0.47	1.41	0.47	0.00	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	34.73	8.04	0.96	0.96	0.64	0.32	0.64	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	18.55	7.13	0.71	0.71	2.14	0.71	0.00	0.71	0.00	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	22.23	5.26	1.75	1.17	0.58	0.58	1.17	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	29.81	4.82	0.30	0.60	0.60	0.60	0.60	0.90	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	20.20	4.75	0.00	0.00	2.38	1.19	0.00	0.00	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	30.51	7.12	1.02	1.02	0.00	0.00	1.02	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	30.82	4.08	1.78	0.00	1.27	0.76	1.27	0.25	0.00	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	22.24	2.54	0.00	1.27	0.64	0.00	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	26.76	4.75	0.00	0.00	0.00	0.86	0.86	2.16	0.00	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	26.04	4.87	0.64	0.42	1.69	0.42	0.21	0.42	0.21	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	18.27	4.06	0.87	0.29	1.45	0.00	0.58	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	26.45	4.72	0.94	0.94	0.94	0.94	1.89	1.89	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	28.99	6.61	0.85	0.85	1.19	0.34	1.02	0.34	0.17	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	20.85	4.63	0.00	0.00	2.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	31.69	2.11	0.00	0.00	0.00	0.00	0.00	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	26.37	6.43	0.86	1.07	1.50	0.21	1.07	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	16.85	6.62	0.00	0.00	1.20	0.60	0.00	0.00	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	28.43	5.83	1.46	0.00	0.73	1.46	0.73	1.46	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	29.88	6.67	0.69	0.23	1.61	0.46	1.15	0.46	0.00	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	17.85	7.65	0.00	0.00	5.10	0.00	7.65	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	19.07	6.86	1.53	0.25	1.78	0.51	0.00	0.51	0.00	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	33.24	7.02	0.41	1.03	0.21	0.21	0.21	0.41	0.62	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	20.20	5.20	0.61	0.61	0.92	0.00	0.31	0.31	0.00	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	22.47	5.26	0.00	0.00	0.48	0.96	1.43	0.96	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	29.49	6.43	0.89	0.22	2.00	0.22	0.89	0.44	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	9.15	1.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	24.92	6.09	1.66	0.55	0.55	0.55	0.55	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	27.27	6.62	0.26	0.26	1.32	1.06	1.06	1.06	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	20.72	5.09	0.73	0.00	0.73	0.36	0.36	1.45	0.00	0.73
Astrocyte - cerebellum, donor1	11500-119F6	44.95	15.47	5.65	6.14	0.86	1.72	1.11	0.12	0.49	0.74
Astrocyte - cerebellum, donor2	11580-120F5	46.38	11.13	2.74	2.57	1.20	1.88	0.34	1.20	0.34	0.86
Astrocyte - cerebellum, donor3	11661-122F5	50.76	7.34	5.03	3.57	0.63	1.68	0.63	0.21	0.42	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	32.77	6.97	8.71	5.23	1.39	2.09	0.35	0.35	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	57.75	12.46	6.96	3.24	0.32	1.78	0.65	1.46	0.16	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	48.03	7.01	5.22	2.98	0.75	1.64	1.49	1.19	0.45	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	118.13	3.10	1.49	1.61	0.46	2.98	0.92	2.06	0.11	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	111.00	3.88	1.25	1.13	1.38	4.13	0.63	0.63	0.00	0.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	93.77	5.23	1.37	1.37	0.34	3.41	0.68	1.02	0.00	0.46
Basophils, donor1	12241-129G9	86.04	13.86	1.57	0.26	1.83	2.35	1.05	0.78	1.57	0.26
Basophils, donor2	12242-129H1	79.01	9.38	1.44	0.36	1.80	1.08	1.80	0.36	1.08	0.72
Basophils, donor3	12243-129H2	77.91	11.91	1.03	1.62	1.32	0.88	0.88	0.59	2.20	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	50.88	2.37	0.00	0.65	0.22	1.72	0.22	0.43	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	62.18	5.94	0.00	1.83	1.37	1.83	0.00	0.00	0.00	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	7.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	28.24	4.39	0.00	0.00	1.26	1.26	0.00	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	43.25	4.99	0.00	0.83	0.83	0.83	0.21	0.42	0.00	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	40.30	7.83	0.69	1.15	0.92	0.46	0.46	1.15	0.23	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	42.47	2.88	0.54	1.08	0.54	1.62	0.00	1.44	0.00	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	40.71	8.35	3.09	1.75	0.21	1.85	0.10	0.31	0.00	0.93
Burkitt's lymphoma cell line:RAJI	10476-106I8	40.06	3.96	2.33	3.26	0.00	3.26	0.00	1.16	0.00	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	68.75	6.08	4.16	3.84	0.32	1.60	0.96	0.00	0.32	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	93.08	10.34	0.00	20.68	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	87.91	12.96	1.13	0.00	2.82	1.69	1.69	0.00	9.02	0.56
CD14+ Monocytes, donor2	11305-117B9	129.92	10.58	1.30	1.30	1.11	3.53	1.67	1.86	8.91	0.56
CD14+ Monocytes, donor3	11381-118B4	107.57	7.68	1.10	1.32	0.22	2.85	1.32	0.44	3.51	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	46.99	8.21	0.57	3.96	2.26	0.85	0.85	0.85	0.28	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	45.87	5.69	0.76	1.14	3.41	0.00	1.14	1.14	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	56.87	7.89	1.64	2.96	2.96	0.99	2.30	0.66	0.33	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	154.67	20.96	2.89	6.36	7.95	2.46	3.76	4.19	9.40	1.88
CD14+ monocytes - mock treated, donor2	11873-125C1	120.40	23.54	4.22	4.83	3.62	3.62	3.92	4.22	7.85	2.41
CD14+ monocytes - mock treated, donor3	11883-125D2	139.06	30.80	3.55	3.79	7.58	3.79	2.37	3.79	12.08	1.42
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	99.10	16.07	1.00	3.35	5.19	2.68	2.01	2.18	4.85	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	94.95	12.70	2.48	2.48	3.86	1.93	2.76	1.93	4.97	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	97.19	9.67	0.50	1.24	3.22	2.23	1.24	1.49	5.45	1.24
CD14+ monocytes - treated with BCG, donor1	11860-125A6	90.85	11.94	0.39	1.37	1.96	1.57	1.17	1.96	3.33	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	74.60	11.93	0.71	0.89	3.92	0.89	1.42	2.49	3.74	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	70.51	10.23	1.09	0.65	3.05	1.96	1.52	1.96	4.79	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	80.07	11.94	0.47	1.17	2.81	1.87	3.04	1.40	2.11	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	100.85	11.62	3.17	1.58	4.22	3.17	3.70	0.53	1.06	3.17
CD14+ monocytes - treated with Candida, donor3	11888-125D7	102.06	14.42	1.11	0.00	2.22	2.22	2.22	2.22	3.33	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	134.77	24.84	2.53	4.91	4.61	3.57	3.57	4.61	6.10	1.64
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	103.37	19.56	2.39	5.79	3.59	2.39	1.80	2.00	6.78	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	65.17	15.41	1.46	1.46	3.33	1.46	1.46	1.25	7.70	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	86.94	10.98	1.14	2.06	2.52	2.29	1.60	2.75	4.80	1.60
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	68.31	16.29	0.68	1.58	2.49	3.17	1.81	0.90	7.46	0.90
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	75.94	11.78	0.87	1.75	1.31	3.06	1.31	3.06	5.67	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	107.60	15.33	0.81	2.42	5.38	2.15	2.96	3.50	4.30	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	114.10	12.21	1.40	2.44	4.88	3.14	3.66	4.19	6.11	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	116.99	24.41	1.68	3.37	5.89	1.68	2.95	2.95	6.31	1.68
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	58.05	5.88	0.18	0.92	0.92	2.94	2.76	2.20	1.10	0.92
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	48.96	5.64	1.76	0.70	1.06	2.11	1.06	1.41	2.82	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	44.75	3.51	0.44	0.88	2.19	0.88	0.44	0.44	2.19	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	111.25	15.69	1.74	1.22	2.79	3.66	2.62	4.71	1.74	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	104.81	8.18	0.74	0.74	1.86	3.72	2.60	1.86	1.86	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	101.31	13.80	1.72	0.86	1.94	2.59	1.08	1.51	3.02	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	55.69	4.09	0.41	0.82	2.05	0.82	1.23	0.82	1.64	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	49.60	6.72	0.70	0.70	1.16	1.62	1.16	0.93	2.78	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	34.57	7.19	1.16	0.70	0.46	0.00	1.86	0.00	4.18	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	60.16	30.08	1.96	0.44	3.27	0.87	1.96	1.74	3.05	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	84.31	46.43	3.00	1.15	3.46	1.85	1.85	2.31	4.16	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	62.39	28.16	1.08	0.65	1.52	1.30	1.08	1.08	2.17	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	105.89	23.51	0.78	0.93	2.34	1.56	4.20	1.40	1.25	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	92.74	19.91	0.35	0.70	2.79	1.05	1.22	1.75	0.52	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	99.44	21.41	1.11	1.56	2.68	1.56	1.78	1.56	0.45	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	100.03	38.02	2.30	0.26	2.55	0.00	0.77	0.26	4.59	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	97.93	44.35	3.07	1.32	6.37	2.20	1.98	2.20	6.59	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	74.32	34.95	1.26	1.05	4.00	0.84	1.05	0.42	5.26	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	40.65	12.19	0.00	0.00	0.00	2.03	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	42.71	10.85	0.68	0.68	0.00	0.68	0.68	0.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	39.35	10.36	1.04	3.11	0.00	1.04	1.04	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	59.70	10.13	1.07	1.60	0.53	1.07	1.60	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	75.59	10.19	1.61	2.68	0.00	1.07	1.07	0.54	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	56.16	7.02	0.70	1.40	0.00	0.70	0.70	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	61.18	10.20	0.00	2.35	0.78	1.57	0.00	0.00	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	48.78	13.18	0.00	1.32	0.00	0.00	2.64	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	57.53	9.86	0.82	1.64	0.82	3.29	1.64	1.64	0.00	2.47
CD19+ B Cells, donor2	11624-122B4	37.72	5.08	2.90	0.00	0.73	0.00	0.73	0.73	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	57.05	6.56	1.51	1.51	0.50	0.50	1.01	0.00	0.50	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	52.12	3.23	0.40	0.40	0.40	2.42	1.21	0.81	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	39.15	1.60	0.00	0.00	1.20	2.00	0.80	0.00	0.00	0.80
CD34+ Progenitors, donor1	11545-120B6	23.09	4.02	2.01	1.00	0.00	0.00	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	49.44	3.37	1.12	0.00	0.00	1.69	1.12	0.00	1.12	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	39.83	7.89	1.88	2.25	0.00	1.13	0.38	0.38	0.38	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	55.02	5.19	3.61	3.16	0.68	2.93	0.90	0.45	0.23	0.90
CD4+ T Cells, donor1	11225-116C1	65.34	7.86	0.00	0.36	0.36	1.79	1.07	0.36	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	66.14	3.06	0.00	0.00	0.61	0.00	0.00	1.22	1.22	0.00
CD4+ T Cells, donor3	11382-118B5	70.45	3.66	0.00	0.30	0.61	0.00	0.61	0.61	0.30	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	48.49	8.68	1.28	1.28	0.00	0.51	0.51	2.04	0.00	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	53.68	8.09	0.45	0.67	0.67	0.67	0.45	0.00	0.00	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	52.32	5.17	0.86	0.29	1.72	0.86	0.57	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	32.24	8.53	0.00	0.95	0.00	0.47	0.00	0.47	0.47	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	54.08	7.02	0.00	1.40	0.70	1.40	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	65.92	3.30	0.00	0.00	0.00	3.30	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	45.38	7.08	0.29	0.72	0.43	0.87	0.43	0.72	0.00	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	56.26	5.42	0.68	0.51	0.17	0.00	0.51	1.02	0.00	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	47.88	4.51	0.00	0.64	0.81	1.13	0.64	0.32	0.00	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	52.90	9.41	0.45	0.45	0.45	0.00	1.34	0.90	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	46.47	7.69	0.35	1.40	0.70	1.40	0.00	1.05	0.00	1.75
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	41.36	7.48	0.44	0.44	0.00	0.44	0.00	0.44	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	29.94	7.59	0.42	0.00	0.00	0.84	0.42	0.42	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	44.05	7.69	0.42	0.21	0.21	1.45	0.00	0.21	0.00	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	43.77	7.68	0.00	0.00	1.34	0.67	0.33	0.67	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	66.90	10.06	0.54	0.54	0.00	0.82	0.00	0.82	0.00	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	64.85	10.18	0.00	0.54	0.54	0.00	0.54	0.54	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	43.04	5.38	1.79	0.00	0.00	0.00	0.00	1.79	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	49.51	5.19	0.37	1.48	0.56	0.93	0.00	1.11	0.19	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	40.94	4.55	0.00	0.22	0.43	1.30	0.22	0.43	0.22	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	47.28	6.30	0.42	0.84	0.63	0.21	0.42	0.00	0.00	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	52.58	9.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	54.59	9.53	0.00	0.43	0.43	1.30	0.43	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	42.71	10.46	0.00	0.87	0.44	0.87	0.44	1.74	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	76.70	10.89	1.48	0.00	0.99	0.99	0.99	0.99	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	68.32	8.31	0.00	0.92	0.00	0.00	0.92	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	34.90	11.17	1.40	0.00	0.00	0.00	1.40	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	76.16	10.80	0.55	1.66	0.00	1.11	0.28	0.55	0.55	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	73.37	7.12	0.49	1.23	0.98	0.74	0.25	0.49	0.00	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	66.22	10.78	0.00	1.54	1.54	3.08	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	93.11	11.82	0.00	0.36	0.72	1.43	0.00	0.36	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	83.10	12.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	44.20	3.93	0.33	0.98	0.33	0.33	0.65	0.33	0.33	0.00
CD8+ T Cells, donor2	11307-117C2	49.18	3.38	0.00	0.75	0.00	1.13	0.00	1.13	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	60.85	4.04	0.50	1.01	0.25	2.27	0.76	0.50	0.00	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	21.10	5.96	1.61	1.61	0.69	0.46	0.46	0.00	0.23	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	16.77	8.87	2.64	0.48	0.72	1.20	0.00	1.20	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	22.98	6.57	2.74	2.46	0.55	0.55	0.27	0.00	0.00	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	21.62	3.90	1.50	1.20	0.90	0.30	0.30	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	22.80	8.64	2.64	2.40	0.72	0.24	0.00	0.72	0.00	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	23.19	6.14	2.96	1.82	0.23	0.68	0.68	0.23	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	25.42	6.95	1.09	2.39	0.43	0.22	0.00	0.87	0.00	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	25.53	7.90	1.58	1.58	0.26	0.26	0.26	0.26	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	26.73	8.21	3.52	1.64	1.41	0.47	0.00	0.70	0.00	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	24.75	6.64	1.21	2.11	0.00	0.60	0.30	0.00	0.00	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	26.15	6.68	2.32	0.29	0.58	0.58	0.00	0.29	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	25.31	6.39	2.13	1.33	0.27	1.33	0.27	0.53	0.00	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	35.02	7.88	2.19	1.75	1.75	2.19	0.44	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	30.97	10.02	1.37	1.82	0.00	0.46	0.91	0.00	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	41.77	4.48	4.48	1.49	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	24.85	9.72	1.80	2.88	1.08	1.08	0.72	0.00	0.36	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	21.00	6.91	2.88	1.44	0.58	0.00	0.00	0.29	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	27.34	7.54	2.12	1.89	0.94	0.47	0.00	0.24	0.24	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	21.23	9.51	2.54	1.27	0.00	0.00	0.00	1.27	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	25.53	6.77	1.54	3.38	0.31	0.62	0.31	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	28.53	8.01	2.56	1.28	0.32	1.60	0.32	0.96	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	19.89	8.41	1.53	1.53	0.00	1.15	0.00	0.00	1.53	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	20.49	9.85	1.58	1.58	0.39	0.39	0.00	0.79	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	16.64	11.35	2.27	1.51	0.76	2.27	0.76	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	47.37	12.85	4.01	0.80	0.00	0.80	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	44.76	11.89	0.70	1.40	0.00	0.70	0.00	0.00	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	46.08	14.02	2.00	4.01	0.00	2.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	85.90	3.66	3.66	1.83	3.66	1.83	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	38.54	5.93	2.47	1.98	1.98	0.00	0.49	0.99	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	43.88	5.79	1.37	0.84	0.21	0.74	0.74	0.32	0.11	0.21
Chondrocyte - de diff, donor1	11261-116G1	33.28	7.63	0.00	0.35	0.35	1.73	1.39	1.73	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	34.12	5.69	0.71	1.78	1.78	0.71	0.71	1.07	0.36	0.36
Chondrocyte - de diff, donor3	11410-118E6	53.13	6.94	1.02	1.82	1.59	0.80	0.80	0.46	0.34	0.34
Chondrocyte - re diff, donor2	11339-117F7	7.16	6.27	1.79	0.90	6.27	1.79	3.58	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	38.42	7.28	0.40	1.62	1.21	0.40	0.40	0.81	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	45.10	13.77	8.49	4.25	0.80	1.72	0.80	0.46	0.34	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	40.83	7.91	5.77	2.57	0.86	2.14	0.21	0.64	0.86	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	48.85	10.80	5.93	4.60	2.12	1.59	1.06	0.35	0.44	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	64.74	10.45	18.98	4.77	4.22	3.30	0.83	0.73	0.83	1.74
Corneal Epithelial Cells, donor1	11526-119I5	52.70	5.71	0.22	0.88	1.32	2.20	0.00	0.22	0.00	0.88
Corneal Epithelial Cells, donor2	11606-120I4	51.19	6.83	0.00	0.00	0.00	0.00	0.00	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	43.71	4.60	0.77	1.02	0.77	1.28	0.26	0.51	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	51.67	5.78	1.16	1.32	1.32	2.31	0.17	0.00	0.66	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	56.46	4.42	1.26	1.26	1.89	1.89	0.32	0.00	0.32	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	62.11	6.90	3.45	0.00	0.00	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	45.36	3.67	1.30	0.97	2.05	1.40	0.11	0.43	0.11	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	36.21	9.22	2.73	2.39	0.34	0.00	1.02	0.34	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	29.38	7.83	0.65	0.00	0.00	0.00	0.65	0.00	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	26.13	8.71	0.97	1.45	0.48	0.97	0.00	0.00	0.00	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	46.20	18.84	3.17	2.67	1.67	0.67	1.67	0.33	0.33	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	48.70	9.98	0.59	1.76	0.59	0.59	2.93	0.00	0.59	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	49.21	14.42	2.83	1.41	1.41	1.41	1.41	0.57	0.00	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	46.00	12.98	3.93	1.18	3.15	1.97	1.18	0.39	0.39	0.39
Endothelial Cells - Artery, donor1	11264-116G4	66.03	11.05	1.75	2.62	1.75	0.29	0.29	0.87	0.29	0.87
Endothelial Cells - Artery, donor2	11341-117F9	65.88	14.12	1.65	4.00	2.35	0.71	0.47	2.35	0.47	0.47
Endothelial Cells - Artery, donor3	11413-118E9	56.80	14.02	2.10	1.05	1.23	1.05	1.75	0.70	0.18	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	50.76	12.86	1.77	2.22	0.89	1.77	2.22	0.44	0.66	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	40.77	14.60	1.52	1.52	1.22	1.52	2.13	0.61	0.30	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	40.03	16.07	2.26	0.85	2.26	1.97	3.10	0.28	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	35.06	18.13	1.19	2.97	1.49	0.89	2.08	0.89	0.00	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	33.84	7.81	0.52	0.52	0.00	1.04	2.08	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	49.48	18.01	2.13	3.40	1.13	1.13	1.84	1.28	0.57	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	53.22	20.81	4.00	2.40	3.20	1.60	2.80	0.40	1.20	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	54.51	13.10	0.52	2.62	2.62	1.05	2.10	1.57	0.00	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	69.33	18.76	3.60	3.85	2.36	1.86	1.99	1.12	0.37	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	62.57	13.04	1.96	2.39	2.61	1.74	1.30	0.00	0.22	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	56.79	14.78	1.95	1.59	1.95	2.56	1.47	0.73	0.37	0.49
Endothelial Cells - Vein, donor1	11267-116G7	45.50	17.06	2.28	1.14	2.28	0.00	0.00	3.41	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	47.50	29.34	3.49	4.89	0.70	1.40	1.40	1.40	1.40	2.10
Endothelial Cells - Vein, donor3	11416-118F3	60.92	14.60	4.24	2.83	2.98	1.26	0.47	0.79	0.63	0.31
Eosinophils, donor1	12244-129H3	45.74	15.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	438.97	128.72	1.65	1.65	13.20	4.95	1.65	1.65	21.45	3.30
Eosinophils, donor3	12246-129H5	395.92	89.17	3.57	3.57	17.83	0.00	0.00	3.57	17.83	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	41.29	3.91	0.49	0.00	0.24	0.98	0.49	0.00	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	62.40	4.16	0.00	0.00	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	47.62	5.75	0.41	0.82	1.23	0.41	0.41	0.82	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	23.32	5.36	0.77	1.42	1.97	0.66	0.22	1.64	0.22	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	43.12	6.93	0.65	2.28	1.30	1.08	0.65	2.17	0.11	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	29.83	5.94	0.97	3.03	1.09	0.73	0.61	0.49	0.24	0.85
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	31.25	2.87	0.27	0.27	1.64	0.27	0.96	0.82	0.00	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	43.98	4.54	0.74	2.00	1.37	1.05	0.84	1.16	0.11	0.84
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	37.15	2.90	1.05	1.05	0.53	0.79	1.05	0.00	0.26	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	49.50	7.97	0.66	2.66	1.00	0.66	0.66	0.66	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	50.81	5.90	0.91	1.36	0.45	0.00	0.45	0.91	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	54.57	10.61	3.03	0.00	0.76	1.52	0.00	1.52	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	41.32	5.84	1.42	2.05	0.47	0.95	0.79	0.63	0.47	0.47
Fibroblast - Cardiac, donor4	11452-119A3	41.83	8.79	2.73	1.52	0.91	0.61	0.91	0.30	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	34.64	9.26	0.76	1.02	0.76	0.76	0.76	0.63	0.00	0.25
Fibroblast - Cardiac, donor6	11460-119B2	29.56	7.73	1.06	2.12	0.61	0.15	0.61	0.30	0.15	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	49.98	13.13	2.41	2.95	1.21	1.21	0.40	0.27	0.13	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	42.28	9.06	2.16	1.73	0.43	1.29	0.86	0.43	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	52.73	1.46	4.39	1.46	0.00	1.46	1.46	5.86	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	104.02	30.44	3.69	3.69	0.92	2.08	0.46	0.00	0.46	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	80.22	14.59	2.54	4.41	2.04	1.19	1.36	0.51	0.68	0.51
Fibroblast - Dermal, donor1	11269-116G9	35.69	6.57	0.94	2.11	1.64	1.17	0.23	0.70	0.70	0.70
Fibroblast - Dermal, donor2	11346-117G5	34.43	10.85	0.47	1.42	1.42	0.94	0.94	0.00	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	47.51	7.01	1.21	1.93	1.69	1.33	0.12	0.73	0.12	0.85
Fibroblast - Dermal, donor4	11450-119A1	34.70	7.80	1.02	0.90	0.90	1.47	0.57	0.90	0.11	0.45
Fibroblast - Dermal, donor5	11454-119A5	38.73	10.64	0.52	1.57	1.40	1.57	0.17	1.05	0.00	0.35
Fibroblast - Dermal, donor6	11458-119A9	37.03	8.93	0.32	0.81	1.79	0.49	0.97	0.49	0.00	0.00
Fibroblast - Gingival, donor1	11237-116D4	34.98	5.41	0.42	0.42	0.21	1.04	0.83	0.62	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	55.02	10.48	2.10	3.67	3.93	1.31	0.26	0.79	0.79	0.52
Fibroblast - Gingival, donor2	11318-117D4	51.66	7.64	1.32	1.45	1.19	1.32	0.66	1.19	0.26	0.79
Fibroblast - Gingival, donor3	11394-118C8	73.19	9.38	0.87	2.71	1.93	1.93	0.68	0.48	0.10	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	31.17	4.16	1.04	3.12	3.12	0.00	1.04	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	54.62	7.58	2.47	4.93	0.70	0.18	0.18	1.06	0.00	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	48.02	10.13	0.62	1.40	2.34	0.94	0.78	0.47	0.47	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	40.30	6.76	0.81	1.35	1.49	0.81	0.68	0.54	0.27	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	92.10	10.59	1.76	3.53	1.76	1.41	0.71	0.00	0.35	1.41
Fibroblast - Gingival, donor7 (control)	11924-125H7	43.58	7.60	1.46	1.75	2.78	0.88	0.58	0.58	0.29	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	36.27	7.23	0.95	0.95	2.05	0.68	1.36	0.82	0.14	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	49.36	12.51	1.97	1.76	2.85	1.86	0.33	0.66	0.11	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	76.60	13.65	2.79	4.26	3.37	1.17	1.32	0.29	0.29	1.76
Fibroblast - Lung, donor1	11270-116H1	47.58	9.52	2.72	1.36	1.36	2.72	0.00	2.72	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	55.21	7.46	0.00	1.49	0.00	2.98	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	77.24	10.55	1.48	1.06	1.48	2.53	1.48	1.27	0.21	1.27
Fibroblast - Lymphatic, donor1	11506-119G3	79.97	11.66	1.67	3.33	0.83	5.83	0.83	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	55.95	6.99	0.00	0.00	2.80	2.80	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	50.38	7.28	0.84	0.84	1.40	1.96	0.84	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	64.14	12.59	1.62	0.81	0.81	4.06	0.81	0.00	0.41	0.41
Fibroblast - Mammary, donor2	11620-122A9	43.94	3.99	0.00	0.00	3.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	59.56	0.00	0.00	5.96	5.96	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	38.99	10.67	1.75	0.58	1.36	1.16	0.97	0.39	0.39	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	65.22	16.53	1.67	0.76	0.91	1.82	1.21	1.67	0.30	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	42.53	8.87	1.84	0.00	1.53	1.22	0.92	0.00	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	52.66	10.69	1.53	2.29	1.91	0.76	0.76	0.00	0.00	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	49.68	6.48	0.81	0.81	1.35	1.08	0.27	2.16	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	57.64	7.77	1.16	3.13	1.86	0.81	0.70	0.23	0.12	1.16
Fibroblast - Pulmonary Artery, donor1	11250-116E8	30.73	7.85	1.66	1.33	0.66	0.33	0.55	0.22	0.11	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	68.27	10.36	2.24	2.24	1.83	2.84	1.02	0.61	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	47.44	6.68	1.34	0.67	2.67	0.00	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	47.44	8.30	1.58	1.58	0.79	0.40	0.00	0.40	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	49.02	4.56	0.20	0.20	0.40	0.20	0.60	0.79	0.60	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	45.65	8.88	0.36	1.24	1.24	1.24	1.07	0.36	0.18	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	33.50	7.10	0.79	0.20	1.58	1.38	0.39	0.59	0.59	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	34.00	6.62	0.30	0.90	2.11	0.00	0.30	0.00	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	46.85	8.31	0.65	1.84	1.73	0.76	0.97	1.19	0.76	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	43.28	1.27	0.25	0.51	0.51	0.51	0.76	1.01	0.25	0.25
Fibroblast - skin normal, donor1	11553-120C5	44.96	7.55	0.49	1.64	1.48	0.98	0.33	0.33	0.16	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	31.68	4.21	0.60	1.40	0.80	0.40	0.40	0.20	0.20	0.00
Fibroblast - skin normal, donor2	11561-120D4	36.97	7.43	0.40	0.90	1.61	1.21	0.60	1.11	0.30	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	57.43	7.25	0.60	0.60	3.02	0.60	1.21	1.21	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	56.58	6.71	0.58	0.91	1.41	0.58	0.66	0.33	0.25	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	52.31	11.97	0.68	2.56	2.74	1.03	1.03	1.20	1.54	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	49.59	4.27	0.33	0.66	0.99	0.66	0.99	0.33	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	35.26	8.20	0.96	1.17	1.70	0.43	0.64	0.43	0.21	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	37.62	8.27	1.52	0.67	0.67	0.34	0.67	0.67	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	57.55	3.61	0.31	1.25	0.47	0.94	0.63	1.25	0.47	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	132.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	35.73	6.10	0.87	0.87	2.61	0.00	0.00	0.00	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	29.47	4.68	0.69	0.35	1.39	1.21	0.52	0.69	0.35	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	31.23	4.16	0.78	0.26	1.56	1.30	0.00	0.52	0.26	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	34.49	5.37	0.51	0.51	2.04	0.26	0.00	0.26	0.26	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	38.28	16.84	13.78	13.01	1.53	1.53	0.00	3.83	1.53	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	31.90	20.42	17.87	12.76	3.19	0.64	0.00	1.28	1.28	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	46.50	11.13	6.28	9.70	2.00	1.43	0.00	1.71	0.57	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	89.07	31.99	84.93	47.98	28.13	2.76	0.55	0.55	0.00	5.52
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	50.92	19.41	37.90	19.64	8.90	1.37	0.91	1.60	0.23	3.20
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	60.43	18.43	19.02	12.88	5.75	2.97	0.59	1.39	0.40	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	96.48	37.01	74.54	42.03	23.53	2.91	1.85	1.32	0.26	4.23
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	60.34	21.20	37.83	21.20	9.46	1.63	0.98	0.65	0.00	3.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	40.24	6.19	3.98	3.98	2.21	2.65	0.44	0.00	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	47.91	16.68	16.25	9.04	0.85	1.70	0.42	1.27	0.28	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	52.21	18.23	20.93	9.24	1.48	1.60	0.99	0.86	0.25	1.72
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	45.40	17.19	15.85	8.06	1.34	0.54	0.54	1.61	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	44.60	14.74	18.34	8.42	0.87	2.23	0.62	1.12	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	36.13	13.84	16.06	9.14	0.69	1.38	0.28	1.52	0.00	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	33.14	9.35	7.73	5.08	1.02	1.22	0.41	1.02	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	53.85	19.17	19.85	11.18	0.46	1.14	1.37	1.14	0.00	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	47.58	21.30	15.20	9.22	1.62	1.12	0.50	1.12	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	60.11	18.80	10.27	7.43	0.44	1.97	0.00	1.09	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	57.03	18.02	28.37	10.05	0.59	2.07	0.00	1.48	0.00	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	43.87	17.17	30.84	10.01	0.79	1.27	0.32	2.38	0.16	1.27
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	57.64	14.52	14.52	8.94	1.34	2.23	0.22	0.45	0.00	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	50.01	18.15	31.05	9.88	0.60	0.60	1.01	1.01	0.60	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	46.82	16.46	26.97	9.67	1.70	2.21	0.00	1.36	0.00	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	54.44	22.35	20.04	10.37	1.15	3.01	0.53	0.44	0.18	1.06
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	67.12	21.02	36.52	12.28	0.83	3.33	1.04	0.52	0.31	2.60
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	50.55	21.18	28.69	11.27	0.68	1.88	0.68	1.02	0.34	1.54
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	55.66	17.37	29.32	9.96	1.33	1.55	0.33	1.11	0.11	1.88
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	50.42	17.97	24.38	8.82	0.83	0.83	0.50	0.67	0.42	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	36.96	16.13	16.13	6.53	1.43	0.82	0.41	0.61	0.20	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	59.83	16.50	27.64	8.66	1.03	0.41	1.24	0.83	0.00	1.65
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	56.03	18.33	29.28	9.80	0.81	1.27	0.35	0.92	0.46	1.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	56.53	16.18	21.18	8.84	0.33	1.50	0.50	1.00	0.17	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	57.53	19.84	24.25	10.14	0.66	2.42	0.00	1.54	0.22	1.76
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	55.47	19.06	23.12	7.01	1.23	1.35	0.49	2.34	0.49	1.48
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	52.03	12.81	23.50	8.75	1.46	0.97	0.97	0.32	0.32	1.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	66.39	17.32	16.36	9.62	0.64	1.28	0.64	2.57	0.00	2.57
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	50.79	18.57	17.15	7.86	0.95	1.99	0.38	1.23	0.28	0.85
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	49.03	20.56	13.13	4.90	1.11	0.95	0.32	0.63	0.63	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	50.48	16.72	17.33	5.17	2.13	0.91	1.22	1.52	0.00	2.13
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	46.94	12.86	12.54	5.85	1.78	0.84	0.10	0.73	0.00	1.36
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	57.96	13.39	13.61	3.51	1.32	1.10	0.44	0.66	0.22	1.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	48.25	15.43	16.55	7.01	1.12	1.68	0.56	1.12	0.28	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	41.29	15.83	10.46	3.43	2.04	1.39	0.83	1.48	0.19	1.39
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	44.39	13.90	6.95	4.81	1.34	0.80	0.27	2.14	0.53	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	56.92	15.61	6.73	4.74	1.99	1.53	0.31	0.61	0.46	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	44.95	13.08	8.68	3.37	2.20	1.17	0.78	0.65	0.13	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	59.09	19.52	5.96	4.34	1.08	0.81	0.54	0.81	0.81	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	61.94	17.33	5.16	4.24	1.11	2.58	0.00	1.11	0.55	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	61.19	13.82	8.33	3.07	1.75	1.54	0.88	0.44	0.22	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	90.25	34.71	9.92	6.94	0.99	0.99	0.99	0.00	1.98	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	63.32	15.57	4.75	1.85	1.45	0.92	0.66	0.26	0.13	1.06
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	61.74	17.35	2.82	2.82	0.61	0.81	0.40	1.01	0.61	1.21
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	59.47	39.65	6.86	6.61	1.78	4.07	0.76	0.51	1.27	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	43.79	20.70	9.55	5.57	1.19	1.00	0.40	0.40	0.80	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	49.46	16.33	12.02	6.47	1.39	1.39	0.62	1.08	0.46	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	62.60	20.05	22.30	9.21	2.25	1.64	0.20	1.23	1.02	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	31.61	15.02	15.65	8.14	0.63	0.94	0.31	0.94	0.31	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	25.15	13.28	12.43	7.06	1.98	1.13	0.00	0.85	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	23.06	16.14	14.76	3.69	5.53	0.46	0.00	0.46	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	17.32	12.37	14.85	9.90	4.95	0.00	0.00	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	34.43	13.15	20.89	10.44	1.16	1.55	0.39	0.39	0.39	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	27.28	12.84	12.84	8.02	3.21	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	27.82	20.87	17.39	15.65	1.74	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	31.57	20.18	21.48	7.81	2.93	0.33	1.30	1.95	0.00	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	33.36	12.35	23.47	10.30	3.71	1.24	1.24	3.29	0.41	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	49.98	19.99	19.99	19.99	6.66	0.00	3.33	6.66	0.00	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	32.16	17.06	26.01	11.75	1.96	2.24	0.28	0.28	0.28	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	32.36	17.65	20.26	8.50	3.27	1.63	1.63	1.31	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	35.23	11.74	26.84	10.90	3.36	1.68	0.84	0.00	0.84	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	39.76	13.68	33.72	14.95	2.86	0.64	0.64	0.64	0.00	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	34.65	16.64	24.80	7.81	0.68	0.68	0.00	0.34	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	20.88	8.35	18.79	8.35	2.09	2.09	0.00	2.09	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	43.53	13.17	36.65	13.17	1.72	1.72	0.00	2.86	0.00	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	42.03	7.10	21.90	8.58	0.89	0.89	0.00	1.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	15.25	13.55	27.11	10.16	1.69	1.69	1.69	3.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	37.69	16.15	28.58	13.25	2.07	0.41	0.41	1.24	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	32.45	19.56	37.74	11.74	0.92	0.69	0.46	1.61	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	10.54	21.07	5.27	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	19.99	11.15	24.60	8.46	0.77	0.00	0.77	1.92	0.38	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	23.80	7.50	18.25	7.17	1.63	0.98	0.65	0.98	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	38.12	11.37	14.05	8.03	3.34	0.67	2.01	0.00	0.00	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	45.08	8.48	27.35	15.03	0.77	1.16	0.00	1.54	0.77	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	40.40	22.94	43.82	10.27	2.05	0.34	0.34	1.03	1.03	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	59.63	12.42	7.45	14.91	4.97	2.48	2.48	0.00	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	56.62	12.27	18.87	12.27	3.30	1.89	0.47	3.30	0.00	1.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	53.71	12.67	25.35	13.88	4.22	0.00	0.00	1.21	0.00	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	46.29	10.68	19.33	8.14	2.03	1.02	1.02	0.51	0.00	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	39.88	15.95	26.32	13.16	3.99	0.40	0.80	0.40	0.00	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	45.88	15.79	31.08	14.80	0.99	2.47	0.00	1.48	0.00	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	37.77	10.62	17.71	7.08	2.36	1.18	4.72	3.54	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	30.92	14.00	27.42	12.25	1.17	0.58	0.00	2.33	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	54.86	14.92	20.63	10.97	3.07	1.32	0.88	0.00	0.00	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	50.86	11.02	20.34	10.17	1.70	0.85	0.00	2.54	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	30.44	4.18	19.10	7.16	1.79	0.60	0.60	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	33.48	9.22	19.41	2.43	1.94	0.97	1.46	0.49	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	33.10	12.55	0.00	1.14	5.71	0.00	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	51.15	10.81	2.49	0.42	2.49	0.83	1.25	2.49	0.42	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	53.97	4.50	0.00	0.00	1.12	1.12	1.12	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	46.62	13.64	0.63	0.95	1.59	1.90	0.95	0.63	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	35.93	5.01	0.84	0.42	2.51	0.84	0.00	0.42	0.00	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	37.13	7.08	0.81	0.70	1.04	1.51	0.23	1.62	0.35	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	38.99	7.26	0.00	0.51	1.01	2.03	0.51	0.68	0.68	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	38.22	6.14	0.23	0.23	1.59	2.05	0.23	0.68	0.23	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	36.29	7.76	0.55	0.55	1.20	0.98	0.33	1.09	0.33	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	34.82	7.31	0.43	0.00	1.07	2.15	0.21	0.64	0.21	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	31.00	5.38	0.43	0.43	0.65	1.72	0.00	0.86	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	30.64	6.10	0.37	0.12	0.50	1.00	0.25	0.75	0.25	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	29.85	4.46	0.17	0.17	0.69	0.51	0.34	0.17	0.51	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	26.59	4.49	0.96	0.32	0.96	1.60	0.00	0.64	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	74.43	16.79	1.68	9.51	0.56	3.92	1.12	0.56	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	60.16	8.22	2.16	1.73	0.43	0.87	0.00	1.73	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	31.73	15.86	2.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	51.50	9.52	6.35	3.53	1.76	0.71	0.35	0.71	0.00	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	46.50	9.44	2.91	3.63	1.45	1.45	0.00	0.73	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	29.55	7.52	2.10	1.40	0.35	1.05	0.35	0.35	0.52	0.87
Hepatocyte, donor1	11523-119I2	46.00	14.53	0.00	1.21	4.84	0.00	0.00	0.00	0.00	3.63
Hepatocyte, donor2	11603-120I1	57.10	9.70	0.00	2.15	8.62	1.08	0.00	2.15	0.00	1.08
Hepatocyte, donor3	11684-122I1	57.06	4.91	0.61	3.07	4.91	0.61	0.00	0.61	0.61	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	63.31	3.92	2.61	4.57	0.00	0.65	0.00	1.31	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	40.20	19.05	1.75	1.22	2.45	0.52	0.35	0.70	0.87	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	44.59	5.63	1.78	1.78	1.51	2.06	0.41	0.82	0.41	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	57.31	9.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	13.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	40.15	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	35.04	5.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00	11.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	43.57	7.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	27.42	0.00	0.00	0.00	0.00	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	58.48	1.62	1.62	1.62	0.00	1.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	20.01	0.00	1.67	0.00	0.00	0.00	0.00	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	29.04	3.63	0.00	3.63	0.00	0.00	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	46.32	3.97	0.00	0.00	0.00	1.32	1.32	2.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	37.69	3.33	0.00	0.00	0.00	0.00	0.00	1.11	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	36.67	15.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	23.93	1.26	0.00	0.00	0.63	0.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	41.76	9.28	1.55	0.00	0.00	1.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	46.51	3.23	0.00	1.29	0.00	0.65	0.00	1.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	48.30	6.44	0.00	0.00	0.00	1.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	47.26	5.70	0.81	0.81	0.81	0.81	0.00	0.81	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	31.49	5.04	0.84	0.84	0.42	0.42	0.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	38.58	4.02	0.80	0.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	35.08	1.85	1.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	32.57	5.66	0.47	0.47	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	34.47	3.63	1.81	0.91	0.00	0.00	0.91	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	31.21	1.08	0.00	0.00	0.00	1.08	2.15	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	53.36	5.08	0.00	3.81	0.00	1.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	35.07	0.64	1.28	0.64	0.00	0.64	0.00	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	49.21	5.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	30.70	2.14	1.43	0.71	0.71	1.43	0.00	1.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	53.09	3.32	0.00	0.00	0.00	0.00	0.00	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	36.42	3.70	0.93	0.31	0.31	0.00	0.00	0.62	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	33.36	3.51	1.76	1.76	0.00	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	56.58	9.43	0.00	0.00	0.00	3.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	41.03	4.17	1.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	70.82	4.43	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	48.63	6.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	41.85	3.49	0.00	0.00	0.87	2.62	0.87	0.00	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	33.75	15.75	0.00	2.25	0.00	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	41.81	3.48	0.00	0.00	0.00	0.00	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	35.20	4.27	0.00	1.07	0.00	1.07	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	49.88	4.16	1.39	0.00	0.00	1.39	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	54.14	11.40	0.00	0.00	0.00	0.00	0.00	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	47.86	8.28	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	66.56	0.00	0.00	0.00	0.00	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	74.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	37.01	2.11	0.00	1.06	0.00	1.06	1.06	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	51.65	4.32	0.49	1.71	1.06	1.55	0.16	0.57	0.33	0.33
Keratinocyte - epidermal, donor2	11349-117G8	31.04	2.93	0.00	1.17	0.59	0.59	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	50.26	6.25	0.28	0.85	0.57	1.23	0.19	0.66	0.28	0.00
Keratinocyte - oral, donor1	11251-116E9	84.12	6.02	0.79	1.82	0.68	3.18	0.45	0.79	0.23	0.45
Keratocytes, donor1	11527-119I6	92.15	38.85	3.09	3.09	2.06	2.06	0.69	0.00	0.69	0.69
Keratocytes, donor2	11607-120I5	36.33	4.69	0.00	0.00	0.00	1.17	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	66.59	7.71	1.38	1.19	0.20	1.38	0.40	0.40	0.00	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	83.52	15.39	0.00	0.00	10.99	6.59	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	35.60	9.71	2.16	2.16	0.00	0.00	0.00	0.00	0.00	2.16
Lens Epithelial Cells, donor2	11609-120I7	65.28	9.69	8.42	4.15	0.35	1.38	1.15	0.35	0.35	0.46
Lens Epithelial Cells, donor3	11690-122I7	53.18	9.38	2.02	2.12	1.92	1.11	0.30	0.50	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	34.98	14.82	2.13	0.47	0.47	1.19	3.32	0.83	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	29.02	10.60	2.23	1.40	0.56	1.12	1.95	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	28.65	15.11	1.57	1.26	1.42	0.63	2.68	0.47	0.16	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	26.89	12.91	1.08	0.54	0.54	0.00	2.15	0.00	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	33.09	12.61	1.26	0.32	1.26	0.95	0.95	1.58	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	30.40	11.21	0.97	1.62	1.73	0.54	1.73	0.97	0.11	0.65
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	22.98	13.95	3.28	0.82	0.82	0.00	2.05	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	27.30	12.39	2.28	1.52	1.77	1.01	0.51	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	28.01	11.40	2.25	1.55	1.69	0.56	2.11	1.41	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	22.94	15.43	2.37	0.40	0.00	0.40	0.79	0.00	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	27.34	12.99	1.74	1.94	0.58	1.36	1.74	0.19	0.19	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	22.59	9.63	1.11	0.00	1.30	0.93	1.85	0.56	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	25.43	15.33	1.05	1.05	2.44	0.00	1.74	0.70	0.70	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	32.68	13.83	1.67	0.24	0.95	0.48	1.67	0.72	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	27.06	12.22	1.92	0.96	1.37	0.41	1.10	0.41	0.14	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	25.56	13.55	2.16	1.23	0.62	0.31	1.54	0.31	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	22.45	9.98	1.25	1.25	1.25	0.00	0.94	0.31	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	30.19	11.53	2.74	0.91	1.65	0.18	1.46	0.55	0.18	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	18.76	8.89	2.30	1.65	0.99	0.00	0.66	0.33	0.33	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	19.92	9.96	1.46	1.17	0.88	0.00	1.46	0.00	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	27.13	10.70	0.50	1.24	1.49	0.00	1.99	0.50	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	20.85	12.12	2.91	1.45	0.48	0.97	1.45	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	19.39	14.81	1.08	0.54	0.54	0.27	1.62	0.81	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	29.97	15.14	1.21	1.36	2.12	0.15	3.48	0.76	0.00	0.91
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	19.70	9.33	2.59	0.52	0.52	1.04	3.11	0.52	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	20.31	11.52	1.68	1.47	1.47	1.05	1.68	0.21	0.21	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	31.73	13.38	2.86	0.90	1.20	0.45	1.65	1.05	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	34.39	15.13	0.69	0.69	0.69	0.69	1.38	0.69	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	22.20	11.48	1.69	0.94	0.94	0.56	2.07	0.19	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	28.52	13.25	1.38	1.48	1.06	1.27	1.91	0.42	0.11	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	27.14	18.41	0.97	0.48	0.48	0.00	1.94	1.45	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	19.85	14.55	2.32	1.65	0.99	0.99	1.65	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	29.61	11.27	1.61	0.74	1.12	0.99	1.86	1.12	0.37	0.87
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	34.80	16.66	1.48	1.11	1.48	0.74	1.85	0.00	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	15.07	11.37	1.98	0.74	1.48	0.25	1.48	0.00	0.00	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	23.37	12.65	1.24	0.82	1.24	0.82	2.20	0.69	0.14	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	24.44	13.83	1.93	0.64	0.64	0.64	0.96	0.96	0.32	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	25.26	20.09	3.35	0.91	1.22	0.91	1.52	0.00	0.00	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	29.67	17.50	2.10	1.68	1.40	0.42	2.10	0.56	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	26.67	10.67	2.49	1.78	0.00	0.71	1.78	1.07	0.36	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	14.54	11.15	2.42	0.97	0.97	0.48	0.97	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	32.68	11.36	1.40	1.09	0.62	0.47	2.18	0.62	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	27.57	13.61	2.15	2.15	0.72	0.72	2.51	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	27.11	17.97	2.61	0.65	1.96	0.33	1.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	24.48	11.30	1.18	1.41	0.94	0.24	1.65	1.18	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	37.99	14.60	1.86	1.61	2.23	0.99	2.97	1.24	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	25.61	13.57	1.28	0.77	0.26	0.00	1.28	0.77	0.00	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	28.34	9.85	1.19	1.19	0.60	1.19	2.09	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	47.59	11.33	0.00	2.27	6.80	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	47.56	9.21	0.77	2.30	3.84	0.77	0.00	2.30	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	30.43	11.88	0.74	0.00	1.48	2.23	0.74	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	41.89	8.89	1.69	2.12	3.39	1.27	0.42	2.12	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	40.79	6.33	0.70	1.41	2.81	1.41	1.41	1.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	35.49	13.08	2.80	0.00	2.80	0.93	1.87	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	37.61	8.76	1.03	0.00	2.06	1.03	0.52	0.52	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	38.06	8.33	1.19	1.19	0.00	0.00	0.00	0.00	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	40.26	9.95	2.04	2.26	4.07	0.45	0.23	0.45	0.23	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	32.86	9.89	2.04	2.33	2.33	0.00	1.16	1.74	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	42.77	8.55	3.15	0.45	1.35	0.90	0.00	0.45	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	50.81	10.57	2.98	2.57	2.98	1.49	0.68	0.68	0.54	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	50.84	8.73	1.54	1.03	3.08	0.51	0.51	1.54	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	44.46	8.47	1.41	3.18	2.12	0.35	0.00	1.06	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	25.99	8.66	1.33	1.33	0.67	1.33	0.00	0.00	0.67	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	42.79	5.60	3.06	3.06	4.08	1.02	1.53	1.02	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	47.76	12.54	3.74	2.13	2.40	1.33	0.27	1.60	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	38.73	9.07	2.46	1.51	1.89	1.32	0.94	0.94	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	46.02	14.11	1.23	0.61	1.23	0.00	0.00	3.07	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	57.08	11.42	1.63	2.45	5.71	0.82	0.00	0.82	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	37.07	7.91	1.87	1.04	3.75	0.83	1.25	1.87	0.62	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	39.52	8.13	1.12	0.84	3.08	0.28	1.96	1.40	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	40.18	15.46	2.06	0.00	4.12	2.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	38.32	8.13	3.48	0.58	3.77	1.16	0.00	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	31.99	7.77	1.20	1.49	3.89	1.20	0.30	1.20	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	47.03	7.75	2.77	1.66	1.66	1.66	0.55	0.55	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	54.79	13.08	3.18	1.06	2.83	0.71	0.71	3.18	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	42.41	9.96	1.11	1.48	3.69	0.37	0.37	1.48	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	46.05	8.06	1.15	3.45	5.76	0.00	0.00	1.15	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	53.73	14.58	0.77	2.69	1.92	1.54	0.77	1.15	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	32.27	6.79	1.13	0.57	4.53	0.00	0.57	1.13	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	41.02	10.67	1.64	0.00	1.64	1.64	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	49.26	11.30	1.36	1.36	1.36	1.36	0.90	2.71	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	35.91	9.34	2.15	1.44	2.87	0.00	0.72	1.44	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	60.50	10.46	1.49	2.24	4.48	0.00	0.00	1.49	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	56.48	11.52	3.72	0.74	2.60	1.11	0.37	2.60	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	36.61	11.20	1.72	1.29	1.72	0.43	0.43	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	48.81	9.42	0.86	0.00	1.71	0.00	0.00	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	52.64	10.99	1.67	2.33	3.33	2.33	0.33	2.67	0.33	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	51.88	9.65	1.21	3.62	4.83	0.60	0.00	1.81	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	59.01	6.40	0.71	2.84	4.27	0.00	0.00	1.42	0.00	2.13
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	50.18	10.66	1.72	1.72	1.72	0.69	0.34	1.03	0.69	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	44.01	12.35	0.54	2.15	1.61	0.54	2.68	2.15	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	55.22	9.43	1.35	0.67	3.37	2.02	0.67	1.35	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	59.27	8.89	2.22	1.85	5.19	0.37	1.11	2.96	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	40.70	6.98	0.00	3.49	1.16	1.16	0.00	1.16	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	67.70	10.58	2.12	4.23	2.12	0.00	0.00	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	56.02	9.60	1.20	2.40	5.60	2.00	0.40	2.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	37.80	10.18	2.91	1.45	1.45	2.18	1.45	1.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	64.39	13.80	2.30	3.07	0.77	3.07	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	51.79	14.31	3.45	0.49	2.47	0.00	0.00	2.47	0.49	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	54.57	9.41	3.76	0.94	1.88	0.00	0.00	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	64.36	7.54	2.51	2.51	2.51	3.02	2.51	0.50	0.00	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	50.47	11.72	1.35	3.15	2.25	0.90	0.45	1.80	0.90	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	39.59	3.44	1.72	1.72	3.44	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	70.36	7.57	3.12	3.56	2.67	1.34	0.45	0.89	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	52.40	4.69	1.56	1.56	5.47	2.35	0.39	2.35	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	46.84	9.24	0.00	0.66	2.64	1.32	1.32	1.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	58.64	10.90	1.56	1.04	3.11	1.56	1.56	1.56	0.00	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	54.26	11.38	1.31	2.19	1.31	1.31	2.19	1.75	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	41.37	8.39	1.68	1.12	4.47	0.56	1.12	2.24	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	52.56	12.37	3.97	1.32	4.42	1.32	2.21	0.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	48.99	8.87	0.39	2.31	3.47	0.77	0.77	1.54	0.00	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	39.50	11.65	1.52	1.01	3.04	0.51	1.01	1.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	62.00	8.17	1.44	1.44	1.92	0.96	0.48	0.96	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	52.08	9.94	1.99	1.59	5.17	0.00	0.00	1.99	0.80	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	38.28	9.11	3.04	0.61	4.25	0.61	0.61	1.22	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	49.80	9.68	0.69	3.46	3.46	0.69	0.00	1.38	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	55.10	12.92	1.52	1.52	4.94	1.14	1.14	0.76	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	43.90	10.33	2.07	1.03	3.10	1.03	0.52	1.03	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	50.79	12.09	1.81	1.81	2.42	2.42	3.63	1.21	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	54.51	7.92	2.85	1.27	2.54	0.00	0.63	1.90	0.32	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	40.51	11.73	0.53	0.53	0.53	1.07	0.53	1.07	1.07	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	51.15	13.22	2.30	2.87	4.02	2.30	0.57	1.72	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	55.02	6.17	2.06	2.06	5.14	2.06	1.54	1.54	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	41.03	12.73	0.71	0.71	2.83	0.00	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	53.91	13.62	2.84	2.27	2.84	0.00	1.70	0.57	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	62.82	12.48	2.08	2.08	3.74	1.25	0.42	1.66	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	28.97	11.75	0.00	1.57	6.26	0.78	0.78	2.35	1.57	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	45.51	13.36	2.09	1.25	1.67	1.25	0.84	1.25	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	41.82	10.69	1.86	0.93	2.32	1.39	0.00	2.32	0.46	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	54.19	8.70	2.01	0.00	3.35	0.67	0.67	0.00	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	50.79	17.11	3.21	0.53	1.60	1.07	1.60	1.60	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	49.30	13.74	2.42	3.23	2.02	0.81	0.81	1.62	0.40	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	42.22	17.44	0.92	0.92	8.26	0.92	1.84	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	58.68	13.34	1.78	1.78	2.67	3.56	2.67	2.67	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	53.00	11.40	1.71	2.85	2.85	1.71	0.57	2.28	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	49.08	14.57	1.53	0.77	4.60	2.30	0.00	0.77	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	65.66	15.87	2.19	0.55	2.19	1.09	0.55	1.09	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	62.81	13.81	1.78	3.12	1.78	2.67	1.78	2.23	0.45	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	54.33	15.86	2.34	3.38	4.68	0.78	0.26	0.78	0.00	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	65.65	18.57	0.00	3.32	2.65	1.99	0.00	1.33	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	58.20	10.39	0.00	6.24	4.16	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	25.30	4.33	0.68	0.68	0.91	0.23	0.00	0.46	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	22.57	2.57	0.55	0.73	1.65	1.10	0.55	0.18	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	32.38	2.88	0.66	0.52	0.92	1.57	0.52	0.52	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	16.46	2.12	0.00	0.00	0.53	0.00	0.53	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	23.29	3.33	0.32	0.48	2.06	1.43	0.63	1.27	0.16	0.48
Mallassez-derived cells, donor3	11930-125I4	27.38	4.86	0.28	0.83	1.25	1.25	0.28	0.42	0.14	0.28
Mammary Epithelial Cell, donor1	11273-116H4	60.68	9.57	0.90	0.70	1.40	1.79	0.70	0.40	0.20	0.40
Mammary Epithelial Cell, donor2	11350-117G9	46.04	6.37	0.58	0.00	0.29	2.03	0.00	0.87	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	41.90	4.74	0.75	0.50	1.50	1.00	0.50	0.50	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	13.56	2.71	0.68	0.00	0.00	2.03	0.68	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	41.53	4.33	1.30	1.51	1.41	0.32	3.57	0.00	0.00	0.65
Mast cell, donor2	11565-120D8	53.49	16.05	2.97	4.75	4.46	1.19	3.86	0.59	0.00	0.59
Mast cell, donor3	11566-120D9	65.51	19.36	2.03	3.60	4.28	0.45	3.38	0.45	0.68	1.80
Mast cell, donor4	11567-120E1	54.78	14.89	1.77	4.79	3.37	0.71	3.55	0.18	0.00	1.42
Mast cell, expanded and stimulated, donor5	11940-126A5	34.49	3.44	0.55	1.22	1.66	0.89	1.66	0.55	0.00	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	26.85	2.92	0.00	6.42	1.75	0.58	1.17	0.58	0.00	1.75
Mast cell, expanded, donor5	11939-126A4	30.97	3.21	0.57	2.06	2.18	0.69	1.26	0.23	0.00	0.92
Mast cell, expanded, donor8	11941-126A6	51.21	7.03	0.50	4.35	5.02	2.01	1.34	0.67	0.00	1.17
Melanocyte - dark, donor1	11502-119F8	41.49	10.05	1.29	1.29	1.69	0.80	4.28	0.70	0.20	1.09
Melanocyte - dark, donor2	11582-120F7	41.53	6.58	2.42	3.11	1.38	0.69	1.73	0.35	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	44.55	8.91	2.39	2.10	0.80	0.87	1.30	0.51	0.22	0.29
Melanocyte - light, donor1	11274-116H5	35.50	7.76	1.65	2.82	2.35	1.18	0.47	0.24	0.24	0.47
Melanocyte - light, donor2	11351-117H1	32.08	9.55	3.41	6.82	4.09	1.36	0.68	0.00	0.68	1.36
Melanocyte - light, donor3	11423-118G1	38.16	13.01	1.73	0.87	0.00	1.73	0.87	0.87	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	36.34	4.37	1.04	1.15	0.62	0.83	0.42	0.94	0.10	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	33.35	4.30	1.08	1.08	2.15	0.00	0.00	0.27	0.27	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	43.66	10.71	2.68	1.61	1.87	0.27	0.27	0.00	0.54	0.27
Meningeal Cells, donor1	11493-119E8	53.84	19.97	4.34	2.73	0.87	2.23	1.36	0.87	0.12	0.25
Meningeal Cells, donor2	11573-120E7	53.70	13.20	2.64	2.20	0.88	2.64	0.00	1.32	0.44	0.44
Meningeal Cells, donor3	11654-122E7	40.75	12.06	3.59	2.69	0.65	1.79	1.71	0.57	0.16	0.57
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	47.62	10.27	2.57	1.43	1.14	1.43	0.00	0.29	0.57	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	27.67	4.83	0.70	0.10	0.60	0.30	0.60	0.20	0.30	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	72.28	9.20	1.31	5.26	1.31	0.00	0.00	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	45.79	2.62	0.00	0.00	0.00	1.31	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	23.68	4.31	0.72	0.00	2.87	0.72	0.00	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	35.15	4.45	1.06	1.27	1.27	1.48	0.64	0.00	0.42	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	39.21	5.53	0.00	1.51	1.51	1.51	1.01	0.50	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	50.98	11.65	1.54	2.42	1.10	1.76	0.88	0.22	0.22	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	49.68	11.69	4.38	2.19	1.46	1.46	0.00	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	49.51	11.66	1.64	0.82	1.02	2.86	0.41	0.82	0.20	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	57.48	9.70	0.42	0.42	1.11	1.39	0.69	0.55	0.14	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	42.38	6.69	2.23	1.49	0.00	0.37	0.37	0.37	0.37	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	61.97	7.24	0.39	1.05	1.05	1.18	0.53	0.66	0.39	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	47.18	8.90	2.08	0.89	0.89	1.19	0.59	0.30	0.30	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	51.38	11.68	0.00	2.34	0.00	0.00	0.00	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	44.83	8.33	2.56	0.00	1.92	0.64	0.00	0.64	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	37.22	6.03	0.71	0.35	1.06	0.00	0.71	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	66.30	5.94	1.56	0.94	0.63	0.31	0.63	0.31	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	42.82	3.63	1.45	1.45	0.73	0.00	1.45	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	35.53	3.98	0.53	0.80	1.33	0.53	0.80	0.27	0.27	0.53
Mesothelial Cells, donor2	12156-128G5	51.55	4.50	2.00	0.50	1.00	0.50	0.00	0.00	1.00	0.00
Mesothelial Cells, donor3	11402-118D7	35.99	4.26	0.87	0.79	1.52	0.79	0.65	0.43	0.22	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	62.11	9.45	0.00	0.00	4.05	5.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	26.35	5.17	0.99	0.25	2.22	0.74	0.00	0.99	0.00	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	32.10	5.30	1.77	1.47	1.77	1.47	0.59	0.29	0.29	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	38.03	6.91	0.00	0.00	0.00	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	16.12	2.48	0.31	0.00	1.86	0.62	0.93	0.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	23.85	3.94	1.24	0.00	1.45	0.62	1.04	0.21	0.00	1.24
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	32.42	4.63	2.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	34.04	5.01	0.50	0.75	2.50	0.00	1.50	0.75	0.00	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	38.63	7.91	2.33	0.47	2.79	0.93	0.47	0.47	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	33.73	4.06	0.41	0.81	1.42	0.61	0.61	1.42	0.20	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	24.55	3.56	1.58	0.79	2.38	0.79	0.40	0.79	0.00	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	0.00	0.00	0.00	8.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	24.78	3.54	0.00	0.00	0.00	0.88	1.77	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	22.42	3.80	1.90	0.76	0.38	0.00	0.38	0.76	0.38	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	22.37	1.32	1.32	0.00	1.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	20.80	1.91	0.21	1.27	0.85	0.42	0.00	0.42	0.00	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	13.81	0.92	0.00	0.92	0.92	1.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	25.63	4.47	0.89	0.89	0.89	0.89	0.89	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	31.86	6.71	1.68	0.00	1.68	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	15.05	2.26	0.00	0.00	0.25	0.50	0.00	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	19.25	2.85	0.48	0.71	1.43	1.90	0.24	0.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.63	1.66	0.00	1.11	2.76	0.00	0.00	0.00	0.00	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	11.74	2.07	0.46	0.00	0.92	0.00	0.23	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	17.67	1.68	0.84	0.00	1.05	0.63	0.21	0.21	0.63	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	20.18	2.45	0.82	0.20	1.22	0.41	0.00	0.00	0.20	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	16.30	2.36	0.64	0.21	0.64	1.07	0.21	0.21	0.21	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	15.78	2.45	0.89	0.89	1.33	1.33	0.44	0.00	0.00	0.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	13.14	2.19	0.66	0.00	0.88	0.00	0.22	0.44	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	14.19	4.56	1.52	1.01	1.01	0.51	0.00	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	0.00	0.00	0.00	1.66	1.66	0.00	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	18.48	2.17	0.00	0.00	1.36	0.82	0.00	0.27	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	14.70	1.47	0.59	0.00	0.88	0.59	0.59	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	18.54	2.18	0.00	0.00	2.18	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	20.18	4.81	0.48	0.48	1.44	0.48	0.00	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	14.41	3.60	0.40	1.20	1.20	1.60	0.00	0.40	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	20.57	1.37	1.37	0.00	0.00	1.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	22.53	2.00	1.00	0.50	1.50	2.00	0.00	1.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	32.62	4.08	0.00	0.00	0.00	4.08	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	20.14	5.26	0.00	1.31	0.88	0.44	0.44	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	17.66	2.21	0.00	0.00	0.00	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	24.98	3.20	0.00	0.00	1.28	1.92	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	26.28	7.93	0.50	0.50	1.24	0.25	0.50	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	14.61	2.09	0.00	0.70	2.78	0.00	0.00	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	19.89	11.05	0.00	0.00	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	21.88	6.50	0.68	0.68	1.03	1.37	0.68	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	18.82	4.38	0.44	1.31	1.31	1.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	20.24	9.59	0.71	0.71	1.07	0.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	16.27	7.29	1.12	0.56	2.24	0.28	0.56	0.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	7.48	2.91	0.00	0.00	1.25	0.00	0.42	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	16.90	6.99	1.17	0.58	2.91	0.58	0.00	0.58	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	17.19	9.05	0.60	1.51	0.90	0.90	0.30	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	12.52	4.17	0.00	0.42	2.09	1.67	0.83	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	12.93	5.54	1.85	0.92	1.85	0.92	0.00	2.77	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	14.23	3.98	0.57	0.57	1.14	1.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	20.17	7.60	0.28	1.24	1.93	0.97	0.69	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	17.36	7.00	1.81	0.26	1.55	1.04	0.52	0.00	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	16.73	6.01	1.29	0.00	1.72	1.29	0.00	0.00	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	20.96	8.26	0.64	1.91	0.64	0.64	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	19.22	9.34	0.80	1.07	1.33	0.80	0.27	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	26.34	5.09	0.60	1.20	3.29	1.20	0.30	0.30	0.00	1.80
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	25.14	6.64	0.99	0.85	2.12	0.57	0.28	0.28	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	12.42	7.64	0.64	0.96	2.87	0.96	0.32	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	22.56	5.31	0.44	0.88	2.65	1.99	0.22	0.66	0.22	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	31.09	6.45	1.14	0.76	1.52	1.52	0.38	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	20.74	5.68	0.85	0.85	0.57	0.57	0.57	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	14.01	6.88	0.49	0.49	2.95	0.98	1.23	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	28.02	7.82	0.65	0.65	7.82	2.61	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	27.64	5.59	2.06	1.76	1.76	2.06	1.47	0.88	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	23.93	5.48	2.02	1.44	3.46	3.17	0.58	0.86	0.29	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	39.15	6.59	0.00	0.82	4.12	2.06	0.00	0.82	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	22.33	5.06	1.49	1.79	2.68	1.19	0.30	0.30	0.00	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	3.77	3.77	0.00	0.00	0.00	7.53	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	10.69	7.13	0.00	0.00	1.78	0.00	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	33.19	4.93	0.66	0.00	2.30	0.00	1.31	0.66	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	17.88	2.10	0.00	2.10	1.05	1.05	0.00	2.10	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	22.93	4.94	0.40	0.00	1.58	0.79	0.40	1.38	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	29.80	11.18	0.93	1.86	6.52	0.00	0.00	1.86	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	22.91	7.51	1.50	0.75	1.88	0.75	1.88	0.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	26.37	4.53	1.07	1.07	1.07	1.07	1.07	0.27	0.00	1.07
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	17.30	3.73	0.11	0.23	1.02	0.45	0.68	0.00	0.11	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	14.00	5.89	0.74	0.00	2.21	0.00	0.00	0.00	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	15.76	6.96	0.73	0.37	2.56	0.37	1.47	0.73	0.73	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	12.44	3.11	0.00	0.00	1.56	0.00	1.56	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	20.31	1.60	1.07	0.00	0.53	1.07	0.53	0.00	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	3.86	0.00	0.00	0.00	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	16.16	8.08	1.01	0.00	3.03	0.00	2.02	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	15.60	2.53	0.84	0.00	2.11	0.00	1.69	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	12.26	2.72	0.00	0.00	0.00	0.00	0.00	1.36	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	17.80	1.27	0.00	1.27	2.54	0.00	1.27	0.00	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	8.91	3.24	0.00	0.00	0.81	0.81	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	22.66	4.53	1.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	29.36	6.52	3.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	14.26	0.00	0.00	9.50	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	28.87	7.97	0.65	0.86	1.51	1.72	0.86	0.86	0.22	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	51.22	4.70	1.57	3.14	1.05	2.09	1.05	0.52	0.52	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	34.04	7.34	0.00	0.67	3.34	0.67	0.67	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	40.48	7.10	0.83	1.25	2.09	1.25	0.83	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	71.11	3.42	0.19	1.71	1.14	3.23	0.38	1.33	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	51.07	4.79	0.00	3.19	0.00	6.38	0.00	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	31.96	4.08	0.00	1.36	3.40	0.00	0.00	1.36	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	224.19	0.00	0.00	0.00	0.00	5.51	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	27.62	2.93	0.42	2.09	3.35	2.09	0.84	1.67	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	37.19	6.28	0.70	1.16	2.79	1.16	0.46	0.23	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	47.02	5.13	0.27	1.35	1.89	0.54	0.81	0.27	0.27	1.08
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	50.46	6.10	1.47	0.84	0.84	1.26	0.63	0.21	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	133.62	0.00	0.00	0.00	0.00	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	36.23	5.96	0.50	0.50	1.49	0.00	0.00	0.99	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	50.89	4.87	1.35	2.17	2.17	0.81	0.54	1.08	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	26.98	5.67	0.91	1.13	0.68	0.45	1.13	1.59	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	55.03	4.90	0.98	2.29	2.29	1.63	0.98	0.33	0.16	0.82
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	53.58	6.38	1.28	1.09	2.19	1.46	2.37	1.46	0.36	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	37.13	7.43	0.00	0.53	1.06	1.59	1.06	0.53	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	35.42	10.21	0.00	2.40	3.00	0.00	0.60	0.60	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	95.83	5.91	0.33	1.97	0.66	3.28	1.31	1.64	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	43.26	3.58	1.30	0.81	1.30	0.33	0.81	1.30	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	67.91	9.70	1.76	1.06	3.17	1.23	0.00	0.71	0.18	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	35.86	7.74	1.41	1.41	1.41	0.70	0.00	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	43.67	12.87	0.00	0.46	0.46	0.46	0.00	1.38	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	35.67	4.50	0.64	2.25	1.61	0.00	0.64	0.96	0.32	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	123.47	5.52	1.38	1.38	0.00	2.41	1.03	2.76	0.34	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	543.62	10.11	2.53	5.06	2.53	10.11	2.53	0.00	2.53	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	59.04	7.13	0.89	1.56	2.01	1.11	0.67	0.22	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	35.99	7.62	0.85	0.85	0.85	0.42	1.27	1.27	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	47.23	7.60	0.95	1.90	1.42	0.95	1.42	1.90	0.71	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	27.47	5.58	0.00	0.43	2.15	0.43	0.43	1.29	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	144.44	0.00	9.03	0.00	0.00	0.00	0.00	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	38.99	6.00	1.00	1.67	2.67	0.33	0.33	0.67	0.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	45.09	6.31	0.90	2.25	1.80	0.45	0.00	0.45	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	23.01	6.35	1.98	1.19	1.98	0.40	0.40	1.19	0.79	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	36.22	4.64	0.00	0.93	2.79	0.00	1.86	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	28.00	3.41	0.00	0.38	2.27	0.00	0.76	2.65	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	30.63	6.52	0.33	1.30	0.65	0.33	0.65	1.30	0.00	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	54.91	6.10	0.44	0.87	1.74	0.44	0.00	0.87	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	47.94	10.85	1.81	0.00	3.17	0.90	0.00	0.90	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	26.46	11.46	0.00	0.00	0.00	0.00	0.88	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	40.56	5.32	0.00	1.99	0.66	1.99	1.33	1.99	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	33.23	7.94	0.00	0.50	0.99	0.50	0.50	0.99	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	35.22	6.13	0.00	0.77	2.68	0.77	0.38	1.15	1.15	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	39.92	4.84	0.60	1.51	1.21	0.60	0.91	0.91	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	39.12	9.06	0.66	2.21	1.55	1.11	0.66	0.00	0.00	1.77
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	23.72	6.10	1.36	1.36	1.36	0.00	0.00	2.71	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	337.23	5.11	0.00	0.00	5.11	15.33	0.00	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	28.05	3.05	0.00	1.22	5.49	0.00	2.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	41.23	5.67	0.31	0.31	1.89	0.63	0.94	0.94	0.00	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	58.41	5.75	0.61	1.51	1.21	0.61	0.30	0.91	0.61	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	30.06	6.33	1.58	1.58	3.16	0.00	0.00	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	165.51	12.47	4.53	2.27	1.13	5.67	0.00	1.13	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	263.01	5.06	0.00	0.00	0.00	10.12	0.00	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	27.83	3.98	0.99	0.75	0.99	1.12	0.50	0.62	0.37	0.25
Myoblast, donor2	11322-117D8	58.50	5.18	0.77	1.92	2.88	1.53	1.15	0.96	0.00	0.19
Myoblast, donor3	11398-118D3	33.46	5.72	1.35	1.01	1.35	1.68	0.34	0.67	0.17	1.01
NK T cell leukemia cell line:KHYG-1	10777-110G3	43.63	21.89	1.02	0.73	2.19	1.17	1.02	1.17	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	46.44	4.92	0.31	1.54	0.92	1.85	0.62	0.00	1.23	0.00
Natural Killer Cells, donor2	11311-117C6	53.98	3.32	0.30	0.90	1.21	1.21	0.60	1.51	0.00	0.90
Natural Killer Cells, donor3	11387-118C1	62.39	2.94	1.29	1.29	1.10	1.29	1.29	0.18	0.55	0.18
Neural stem cells, donor1	11275-116H6	65.69	15.24	14.52	6.53	2.54	1.81	0.36	0.73	0.00	1.45
Neural stem cells, donor2	11352-117H2	40.44	15.41	36.59	21.18	0.00	1.93	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	37.55	10.24	26.17	12.52	0.00	1.14	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	68.25	8.15	9.47	8.37	1.10	1.54	1.32	1.10	0.00	0.00
Neurons, donor3	11655-122E8	39.46	9.04	21.38	10.69	2.47	1.64	1.64	3.29	0.82	0.00
Neutrophils, donor1	11233-116C9	357.28	66.82	1.86	15.78	15.78	4.64	1.86	10.21	4.64	0.00
Neutrophils, donor2	11314-117C9	394.25	92.76	8.70	17.39	8.70	8.70	20.29	14.49	0.00	11.60
Neutrophils, donor3	11390-118C4	528.99	131.94	7.33	17.71	23.82	9.77	3.67	3.67	3.67	3.05
Nucleus Pulposus Cell, donor1	11252-116F1	77.30	11.99	2.85	3.80	1.19	1.31	2.14	0.59	0.59	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	66.75	12.70	2.60	1.30	0.98	0.33	0.65	1.30	0.33	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	51.74	10.23	0.40	1.80	1.40	2.01	0.60	0.40	0.40	0.60
Olfactory epithelial cells, donor1	11933-125I7	49.97	5.64	0.14	0.69	1.24	0.55	1.24	0.96	0.14	0.28
Olfactory epithelial cells, donor2	11934-125I8	51.24	5.50	1.45	0.72	1.30	1.01	1.30	2.17	0.00	0.14
Olfactory epithelial cells, donor3	11935-125I9	46.42	4.99	0.34	1.02	0.91	0.79	0.00	1.36	0.34	0.45
Olfactory epithelial cells, donor4	11936-126A1	72.85	5.06	0.19	0.88	1.17	1.95	0.49	1.17	0.58	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	43.33	9.03	0.00	0.00	0.60	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	57.85	21.06	1.28	2.13	4.68	1.06	0.43	0.43	0.43	1.49
Osteoblast - differentiated, donor2	11353-117H3	36.58	5.72	2.29	3.43	1.14	0.00	1.14	0.00	0.00	2.29
Osteoblast - differentiated, donor3	11425-118G3	47.79	9.93	3.10	1.86	1.24	1.24	0.00	0.00	1.24	0.62
Osteoblast, donor1	11277-116H8	47.49	11.34	2.54	2.93	1.37	0.39	0.78	0.78	0.00	1.17
Osteoblast, donor2	11354-117H4	57.59	5.62	3.51	1.40	0.00	2.11	0.70	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	49.59	8.53	1.42	1.24	1.07	0.89	0.89	0.36	0.53	0.36
Pancreatic stromal cells, donor1	11249-116E7	42.20	4.97	1.94	2.19	1.77	1.18	0.67	0.67	0.42	0.42
Pericytes, donor1	11491-119E6	52.96	10.68	4.23	5.23	0.45	1.45	1.00	0.45	0.11	0.89
Pericytes, donor2	11571-120E5	49.80	13.58	3.62	5.89	0.23	0.91	0.45	0.45	0.00	1.36
Pericytes, donor3	11652-122E5	55.75	8.14	1.63	1.42	1.22	1.83	0.20	0.61	0.00	0.41
Perineurial Cells, donor1	11499-119F5	47.81	7.35	1.36	1.13	0.00	0.68	0.45	0.11	0.34	0.45
Perineurial Cells, donor2	11579-120F4	48.03	7.91	3.68	3.31	1.20	1.29	1.20	0.55	0.28	0.55
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	83.51	10.52	0.96	2.23	3.51	2.55	1.59	0.00	0.96	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	79.83	11.51	1.71	1.96	1.47	1.47	0.98	2.20	3.43	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	84.90	7.51	0.65	2.46	1.81	2.20	0.91	1.16	1.94	0.52
Placental Epithelial Cells, donor1	11278-116H9	26.31	11.72	0.48	1.67	1.67	0.24	0.24	0.24	0.00	0.48
Placental Epithelial Cells, donor2	11355-117H5	29.94	7.76	2.22	0.00	1.11	0.00	2.22	0.00	0.00	2.22
Placental Epithelial Cells, donor3	11427-118G5	43.58	5.69	0.98	2.55	1.37	1.18	0.20	0.59	0.98	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	32.91	4.75	0.32	0.32	1.58	0.95	0.32	1.27	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	30.58	3.94	0.56	2.06	0.94	0.94	0.94	0.00	0.38	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	21.54	2.35	0.26	0.00	1.31	0.78	0.13	0.65	0.26	0.13
Preadipocyte - breast, donor2	11328-117E5	45.93	6.08	0.68	0.23	1.58	1.80	0.23	1.13	0.45	0.68
Preadipocyte - omental, donor1	11468-119C1	40.39	4.69	0.75	1.07	2.13	0.75	0.64	0.64	0.53	1.07
Preadipocyte - omental, donor2	11329-117E6	38.41	6.11	0.87	0.87	3.06	0.00	1.31	0.00	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	52.29	8.88	0.86	0.86	1.72	1.58	0.72	1.00	0.14	0.29
Preadipocyte - perirenal, donor1	11469-119C2	30.51	2.95	0.98	0.00	1.97	1.97	0.00	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	35.32	7.37	1.23	2.15	1.54	0.61	0.31	0.00	0.31	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	48.52	7.08	1.59	1.77	1.77	1.42	0.89	1.95	0.18	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	38.82	4.09	1.36	2.38	1.02	0.85	1.02	0.17	0.34	0.68
Preadipocyte - visceral, donor1	11280-116I2	36.61	5.40	1.40	1.77	2.33	1.21	0.28	0.19	0.19	0.19
Preadipocyte - visceral, donor2	11357-117H7	43.72	5.52	0.00	0.92	3.22	0.92	0.46	1.84	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	36.05	4.91	0.42	1.78	1.36	1.15	0.31	0.73	0.31	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	22.78	15.84	3.32	3.77	2.41	0.15	0.00	0.45	0.45	0.60
Prostate Epithelial Cells, donor2	11331-117E8	41.30	4.74	0.81	2.84	1.49	1.49	0.54	1.35	0.00	1.22
Prostate Epithelial Cells, donor3	11404-118D9	58.36	2.76	0.55	3.31	0.61	1.29	0.12	0.37	0.12	0.67
Prostate Stromal Cells, donor1	11254-116F3	35.88	8.54	2.05	1.82	1.14	0.68	0.80	1.37	0.46	0.23
Prostate Stromal Cells, donor2	11332-117E9	55.94	12.19	2.15	1.79	1.26	1.61	0.36	1.08	0.00	0.18
Prostate Stromal Cells, donor3	11405-118E1	61.00	7.61	1.56	3.44	1.46	0.52	0.63	1.25	0.21	1.04
Renal Cortical Epithelial Cells, donor1	11516-119H4	60.59	14.96	4.38	3.28	0.36	1.82	0.73	0.73	0.36	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	55.31	8.94	1.59	1.18	1.39	2.29	0.49	0.35	0.21	0.55
Renal Epithelial Cells, donor1	11517-119H5	62.90	15.22	4.57	5.07	0.51	5.07	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	51.22	12.80	5.69	0.71	2.13	2.13	0.71	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	65.85	9.95	1.69	1.69	1.38	2.65	0.32	0.85	0.32	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	46.98	15.66	1.36	2.04	1.36	2.04	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	59.43	16.17	2.02	3.10	1.21	1.75	0.94	1.35	0.27	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	49.29	13.32	5.11	1.78	2.00	1.78	0.89	0.67	0.44	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	45.92	11.98	1.33	1.33	2.66	0.00	0.67	0.67	0.00	1.33
Renal Mesangial Cells, donor1	11518-119H6	52.60	11.66	6.82	2.42	0.44	1.54	1.10	0.44	1.10	0.00
Renal Mesangial Cells, donor2	11598-120H5	51.41	13.79	1.25	4.39	0.63	1.25	1.88	1.25	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	57.15	12.21	5.55	2.50	2.50	1.66	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	45.09	13.15	1.61	0.54	0.81	1.07	0.00	0.81	0.27	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	23.19	7.17	1.27	0.84	0.84	1.27	0.00	1.27	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	51.68	16.39	3.09	1.74	1.35	1.54	0.77	0.77	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	61.71	3.11	1.81	1.81	0.26	1.56	1.04	1.04	0.52	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	59.41	3.13	3.98	1.99	0.28	1.42	0.28	0.28	1.14	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	48.37	7.20	0.00	1.03	2.06	1.03	0.00	2.06	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	35.88	5.52	2.01	2.26	0.75	2.26	0.00	0.00	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	65.88	8.02	1.47	4.54	3.34	1.34	0.80	0.40	0.27	1.07
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	29.48	2.68	1.79	1.79	2.68	1.79	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	31.37	2.20	0.00	1.65	1.65	0.55	0.55	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	29.00	4.06	0.58	1.16	0.58	2.32	1.16	0.58	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	43.43	6.76	1.17	1.04	0.39	1.43	0.39	1.56	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	54.32	5.56	0.89	1.39	0.40	1.99	0.60	0.40	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	43.28	4.46	0.33	0.67	1.00	2.45	0.67	0.56	0.33	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	54.33	4.22	0.62	0.99	0.12	1.61	0.37	0.62	0.00	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	59.09	5.24	1.28	1.86	0.58	1.75	0.47	0.93	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	55.93	4.39	0.46	0.69	1.16	2.54	0.00	0.69	0.00	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	57.78	3.29	0.14	1.51	0.68	1.78	0.14	0.41	0.55	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	50.98	5.60	1.06	1.51	0.30	1.66	0.76	1.82	0.15	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	46.05	4.12	0.36	0.72	0.54	1.61	0.00	0.18	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	57.53	4.16	0.57	0.57	0.29	2.44	0.14	0.43	0.57	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	52.37	3.86	0.54	1.40	0.32	2.36	0.21	1.29	0.54	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	53.77	3.76	1.11	0.44	0.66	2.21	0.22	0.66	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	57.93	4.59	0.57	0.76	0.76	1.53	0.19	0.57	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	54.22	4.66	0.93	1.49	1.30	2.98	0.00	1.02	0.28	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	42.84	5.26	0.75	0.38	1.13	3.01	0.00	0.00	0.75	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	54.81	4.91	1.06	0.80	0.40	2.52	0.27	0.93	0.80	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	56.36	4.96	1.36	0.78	1.07	2.14	0.19	1.65	0.29	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	47.93	3.63	0.38	0.57	1.15	1.72	0.19	0.38	0.57	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	48.80	5.13	0.85	0.75	0.85	2.35	0.43	0.32	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	46.53	4.20	0.56	1.68	0.84	1.68	0.28	1.96	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	45.97	4.96	0.34	0.51	0.17	3.59	0.68	0.34	0.00	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	47.77	5.83	0.55	0.36	0.55	1.46	0.55	0.55	0.36	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	50.28	4.05	0.49	1.23	0.49	1.72	0.37	0.74	0.61	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	48.76	4.30	0.94	0.94	0.54	1.88	0.54	0.13	0.67	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	48.59	7.55	0.47	0.94	0.71	2.12	0.24	0.94	0.47	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	47.02	6.55	0.40	0.79	0.40	1.59	0.79	1.19	0.60	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	46.30	3.27	0.94	0.70	0.23	2.57	0.23	0.47	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	46.03	5.18	0.21	0.62	0.62	1.87	0.41	0.83	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	36.50	3.32	0.66	1.33	0.88	2.21	0.66	1.99	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	46.37	6.89	0.84	1.25	0.21	2.51	0.00	0.63	1.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	48.18	5.11	0.40	0.54	1.08	1.21	0.67	1.21	0.40	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	63.69	6.98	0.51	1.36	0.68	3.07	0.34	0.68	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	50.32	5.40	1.35	1.16	0.58	2.89	0.19	0.77	0.58	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	52.10	5.85	0.34	1.55	0.52	1.72	0.00	0.52	0.69	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	53.77	5.21	0.82	0.96	0.55	1.65	0.41	0.27	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	48.27	6.40	0.66	1.48	1.81	1.97	0.49	0.49	0.16	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	56.24	5.45	0.17	1.53	0.51	2.05	0.68	0.85	0.00	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	57.11	5.62	1.04	1.48	0.59	1.78	0.59	1.04	1.04	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	46.91	3.47	0.53	0.53	1.07	1.87	0.80	0.80	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	59.18	7.19	0.55	2.21	0.41	2.77	0.14	0.41	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	53.81	3.57	0.95	1.90	0.95	2.62	0.95	0.00	0.48	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	73.36	5.04	1.01	0.81	0.40	2.82	0.81	0.40	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	47.93	4.61	0.38	2.45	0.47	1.70	0.19	0.47	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	60.44	4.89	1.40	1.05	2.45	1.75	0.00	1.05	1.75	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	47.45	7.25	1.51	1.51	0.91	1.21	1.81	0.30	0.91	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	46.87	1.96	0.61	2.57	0.37	1.10	0.86	1.35	0.24	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	58.80	8.59	1.02	1.16	1.89	2.62	1.02	0.44	1.60	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	43.20	3.65	2.43	1.22	2.43	1.22	0.00	1.22	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	48.53	3.01	0.30	1.21	0.60	2.41	0.00	0.90	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	56.55	4.98	1.13	5.88	1.36	1.81	0.23	0.68	0.45	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	58.11	5.99	0.90	2.10	2.70	1.20	0.60	0.60	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	33.53	7.32	0.71	5.90	1.53	1.53	0.83	0.35	0.47	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	36.71	7.90	1.28	6.83	1.92	0.85	0.43	0.43	0.43	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	36.66	4.21	1.20	3.00	4.21	1.20	0.00	1.20	1.20	1.80
Schwann Cells, donor1	11498-119F4	53.04	16.74	1.88	3.95	0.94	2.07	0.94	0.38	0.19	0.75
Schwann Cells, donor2	11578-120F3	13.61	17.01	0.00	3.40	3.40	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	44.91	12.27	2.41	2.85	1.97	0.22	0.66	0.44	0.22	1.10
Sebocyte, donor1	11220-116B5	66.83	8.76	0.55	1.64	0.00	2.19	0.55	0.00	0.00	0.55
Sebocyte, donor2	11301-117B5	49.63	4.14	0.00	0.92	1.84	2.30	0.46	1.84	0.46	0.00
Sebocyte, donor3	11378-118B1	73.58	4.95	1.03	1.44	1.44	1.24	0.62	1.03	0.41	0.41
Sertoli Cells, donor1	11255-116F4	41.41	6.63	0.00	1.66	4.97	1.66	0.00	1.66	4.97	0.00
Sertoli Cells, donor2	11333-117F1	33.89	0.00	0.00	5.65	5.65	0.00	2.82	2.82	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	48.83	13.28	2.90	2.99	0.88	0.70	0.18	0.44	0.26	0.53
Skeletal Muscle Cells, donor2	11358-117H8	45.54	7.23	5.06	2.89	0.00	1.45	0.00	0.00	0.72	0.72
Skeletal Muscle Cells, donor3	11430-118G8	69.39	10.03	5.02	4.18	1.67	0.84	0.84	1.67	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	28.75	4.71	1.73	1.73	0.47	0.63	0.47	0.94	0.00	0.16
Skeletal Muscle Cells, donor5	11455-119A6	31.22	5.65	1.78	1.34	1.93	1.64	0.74	1.19	0.15	0.30
Skeletal Muscle Cells, donor6	11459-119B1	33.70	9.08	2.15	1.69	0.62	0.62	0.92	0.77	0.15	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	52.54	11.47	2.52	1.89	1.51	1.76	1.51	0.50	0.50	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	50.37	9.99	2.43	2.43	1.85	1.28	0.43	1.14	0.57	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	46.63	8.53	3.67	2.68	1.39	2.28	0.79	1.19	0.30	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	50.64	9.35	3.20	3.62	0.93	1.18	0.76	0.00	0.67	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	50.66	5.07	2.17	0.72	0.72	0.72	0.00	1.45	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	28.21	7.98	1.65	2.20	1.24	0.83	0.83	0.55	0.41	0.41
Skin - palm, donor1	10286-104F7	40.29	2.69	0.00	0.00	0.00	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	31.28	4.76	0.43	0.86	0.72	1.59	0.72	0.72	0.00	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	39.26	4.09	0.00	0.00	0.00	2.45	0.00	1.64	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	33.50	4.28	0.65	0.91	1.04	0.91	0.00	0.78	0.26	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	26.97	6.39	0.00	2.09	2.36	0.70	0.70	0.70	0.00	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	40.51	8.02	0.42	2.95	2.25	1.27	0.42	0.14	0.00	0.98
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	42.29	4.44	0.21	0.85	0.63	1.69	0.63	0.00	0.21	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	60.49	6.37	0.67	2.17	1.65	1.57	0.15	0.45	0.07	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	66.96	9.87	0.62	2.16	1.85	0.00	0.31	1.85	0.31	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	33.79	3.56	0.67	1.33	0.44	0.67	0.67	0.44	0.67	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	48.20	10.58	0.59	0.00	0.00	0.00	0.59	0.59	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	40.44	7.51	0.88	2.21	2.65	0.66	0.44	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	32.29	8.66	2.36	1.58	1.18	1.18	0.39	0.39	0.00	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	37.08	6.95	3.09	0.77	1.55	1.55	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	67.05	11.01	2.00	0.00	2.00	0.00	1.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	40.72	8.25	0.67	0.53	1.86	1.06	0.00	0.40	0.13	0.67
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	42.34	7.54	2.66	1.33	2.66	0.66	0.22	1.55	0.22	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	13.32	7.17	0.51	0.77	1.41	0.26	0.51	0.13	0.13	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	27.68	6.51	0.65	1.95	0.33	0.98	0.98	0.65	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	25.10	7.97	1.18	0.00	1.77	0.89	0.30	0.00	0.89	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	33.03	4.84	0.43	1.42	2.14	1.42	0.28	1.00	0.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	46.36	8.13	0.81	1.63	0.33	1.14	0.16	0.00	0.16	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	54.80	7.61	2.74	1.52	1.22	0.61	0.91	0.30	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	64.91	8.59	1.77	1.26	2.78	1.52	0.76	0.76	0.76	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	104.05	6.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	41.96	10.01	1.91	0.00	1.43	1.43	0.95	1.91	0.48	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	29.05	5.31	1.03	0.88	0.29	0.74	0.29	0.00	0.59	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	43.05	6.67	1.51	1.94	1.51	0.43	0.22	0.43	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	37.99	7.45	2.10	1.15	1.57	0.84	0.94	0.73	0.21	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	38.98	7.73	1.55	2.32	1.55	0.77	0.62	0.00	0.46	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	35.57	7.55	2.16	1.08	1.08	2.16	4.31	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	30.18	5.08	1.49	0.60	0.60	0.30	0.30	0.30	0.00	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	62.82	12.97	2.05	2.39	0.68	2.05	0.34	0.00	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	78.37	10.05	1.10	1.26	0.39	1.18	1.18	0.55	0.39	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	38.14	11.07	1.11	4.93	4.53	1.31	0.20	0.91	1.01	1.21
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	46.19	10.01	0.68	0.91	1.59	1.14	0.91	0.23	0.00	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	29.59	10.26	0.00	1.21	0.60	0.00	0.00	1.81	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	56.43	16.69	4.50	3.44	2.12	1.85	1.32	0.00	0.00	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	38.62	8.52	1.07	2.40	1.60	1.20	1.07	0.53	0.13	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	59.23	10.64	2.25	3.38	1.75	1.50	0.38	1.13	0.25	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	34.75	7.10	2.03	1.27	1.52	1.01	1.01	0.25	0.51	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	45.68	9.50	1.06	1.66	1.81	0.60	0.30	0.30	0.15	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	43.51	6.75	0.00	1.50	1.50	0.75	0.75	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	158.94	18.09	0.00	3.88	3.88	0.00	1.29	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	65.11	15.35	1.40	2.33	2.79	0.00	0.93	0.00	0.93	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	44.93	7.57	1.01	1.01	2.02	0.00	0.50	0.50	0.00	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	44.19	8.78	0.31	0.94	3.45	0.94	0.31	0.31	0.31	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	46.02	7.96	2.65	0.59	2.36	1.77	0.29	0.59	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	36.74	17.74	2.33	2.17	1.83	0.83	0.83	0.17	0.50	0.50
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	46.72	10.28	1.40	1.40	1.40	0.47	0.47	0.47	0.47	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	32.53	10.36	0.43	1.15	2.88	0.58	1.58	0.00	0.29	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	35.95	7.90	0.76	1.02	1.53	1.02	0.76	0.25	0.00	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	33.85	8.27	1.13	0.75	0.56	1.32	0.75	0.56	0.00	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	47.37	6.71	1.40	1.40	0.98	1.68	0.42	0.28	0.14	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	50.11	8.97	1.34	0.92	0.59	0.84	0.67	0.42	0.25	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	63.33	3.81	0.95	0.95	0.00	0.48	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	41.35	10.03	1.22	0.73	1.22	0.98	0.73	0.24	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	45.96	10.38	2.21	2.87	1.10	1.33	0.44	0.44	1.33	1.99
Smooth Muscle Cells - Uterine, donor3	11466-119B8	29.55	2.34	0.29	0.29	0.29	0.59	1.17	0.88	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	47.23	5.44	0.58	2.33	1.17	1.17	0.78	0.97	0.58	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	30.15	6.08	0.53	0.79	1.85	1.32	1.59	0.79	0.26	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	30.13	5.95	0.00	2.60	2.23	0.37	1.49	2.23	0.00	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	41.68	6.83	1.08	1.44	1.44	0.36	0.72	1.08	0.72	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	22.43	4.54	0.57	0.57	0.85	1.42	0.00	0.28	0.85	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	21.27	6.70	0.39	1.97	3.15	0.79	1.18	0.39	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	30.47	5.59	0.25	1.27	1.27	1.02	1.27	1.27	0.25	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	57.50	3.19	0.40	3.19	2.40	2.40	1.60	0.00	0.00	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	45.56	2.51	0.42	1.67	0.84	1.67	0.00	1.25	0.84	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	46.75	4.58	0.46	1.38	1.83	0.46	0.46	0.46	0.46	0.46
Synoviocyte, donor1	11291-117A4	43.26	8.08	0.50	0.67	1.51	1.18	0.67	0.34	0.50	1.01
Synoviocyte, donor2	11368-117I9	51.29	4.02	1.01	2.35	1.34	0.84	1.17	1.17	0.34	0.50
Synoviocyte, donor3	11440-118H9	53.62	3.57	0.89	1.56	0.67	1.79	0.67	0.89	0.45	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	67.89	10.01	1.79	1.07	0.71	2.14	0.71	0.00	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	69.37	7.93	0.00	1.98	0.00	3.96	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	75.48	13.20	3.47	2.78	1.16	3.70	0.46	1.39	0.23	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	27.38	5.23	0.14	0.65	0.50	1.43	0.07	0.36	0.00	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	36.72	5.41	0.00	0.77	0.39	0.77	0.39	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	33.79	6.87	0.00	0.57	0.00	1.15	1.15	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	70.12	9.60	0.86	4.80	3.44	1.60	0.62	0.37	0.49	0.74
Urethra, donor2	10319-105A4	64.74	8.99	0.00	0.00	10.79	1.80	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	54.19	4.78	0.53	1.86	1.33	1.59	0.27	0.27	0.53	0.27
Urothelial Cells, donor2	11600-120H7	47.67	5.21	0.80	0.40	0.80	1.20	0.00	0.80	0.40	0.40
Urothelial Cells, donor3	11681-122H7	58.91	4.35	1.15	0.46	0.46	1.15	0.23	0.92	0.69	0.23
Urothelial cells, donor0	11216-116B1	85.15	6.91	0.22	0.45	0.45	1.56	0.45	0.22	0.22	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	195.75	24.91	0.89	1.78	1.78	2.67	0.89	3.56	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	182.99	25.73	0.00	0.00	4.29	5.72	0.00	2.86	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	147.86	19.85	1.37	0.68	0.68	4.11	0.00	3.42	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	102.96	21.00	1.72	0.00	3.44	2.07	0.34	0.00	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	125.50	29.05	0.58	1.16	5.23	0.58	1.16	2.32	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	159.31	35.40	0.00	2.08	5.21	2.08	1.04	3.12	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	126.66	24.78	0.00	0.00	5.51	3.67	0.92	1.84	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	159.76	18.26	0.00	0.00	1.83	2.74	0.91	3.65	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	46.75	7.65	6.17	4.32	0.99	1.97	0.62	0.74	0.74	0.12
Wilms' tumor cell line:HFWT	10597-108E3	26.40	7.04	1.76	5.28	0.00	0.00	0.00	0.00	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	51.12	2.23	1.12	0.00	0.28	3.35	0.00	0.84	0.00	0.00
achilles tendon, donor2	10292-104G4	72.33	6.20	0.00	4.13	16.53	4.13	2.07	6.20	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	53.29	8.67	1.27	2.04	0.25	3.57	0.76	0.76	0.00	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	51.31	10.45	3.02	3.95	0.00	3.71	0.70	0.00	0.00	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	66.83	12.46	16.50	10.09	0.00	2.26	0.47	0.24	0.00	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	67.21	4.08	1.36	4.35	0.54	3.54	0.54	0.82	0.00	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	45.54	5.90	6.46	2.53	0.84	2.25	1.12	0.84	0.00	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	48.01	6.56	1.69	1.90	0.85	0.63	0.85	0.00	0.42	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	52.26	3.27	1.63	2.18	0.54	2.18	0.82	0.82	0.00	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	36.57	4.41	2.20	2.20	0.44	1.32	0.44	0.44	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	37.16	2.45	0.00	2.04	0.00	1.63	1.23	1.63	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	50.87	10.10	2.33	4.66	1.16	1.55	3.49	0.39	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	32.57	1.84	0.74	0.37	0.18	1.29	0.37	0.37	0.37	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	31.20	3.90	7.80	0.00	0.00	3.90	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	52.52	13.71	3.02	4.18	0.70	0.23	1.39	0.93	0.00	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	71.20	6.47	3.37	3.11	0.26	1.04	0.78	1.04	0.78	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	46.47	4.38	0.58	1.17	0.29	0.88	0.58	0.29	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	72.50	12.08	0.93	1.39	1.39	1.39	1.39	0.93	0.46	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	24.68	2.88	0.41	0.41	0.82	0.82	1.65	1.23	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	60.16	5.53	0.61	0.31	0.31	2.15	0.92	1.84	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	69.55	2.13	3.41	0.43	0.85	2.56	2.13	0.43	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	63.69	5.16	1.82	1.52	0.91	1.52	1.82	0.30	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	67.88	5.54	1.20	1.44	0.48	1.68	1.20	0.48	0.00	1.20
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	53.23	5.35	0.22	0.89	0.45	2.00	0.67	2.00	0.45	0.89
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	54.70	3.00	2.00	0.67	0.00	3.00	0.00	0.33	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	33.45	5.57	3.72	1.86	0.00	7.43	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	52.36	2.26	2.64	1.51	0.75	1.88	0.38	0.38	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	96.39	2.62	6.54	3.05	1.31	2.62	2.18	0.44	0.44	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	26.24	11.25	0.00	0.00	1.87	1.87	5.62	0.00	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	67.35	4.47	0.47	0.47	0.94	1.65	0.00	0.47	0.24	0.24
adipose tissue, adult, pool1	10010-101C1	54.45	6.67	0.93	4.96	2.95	2.48	1.09	0.47	0.00	0.93
adipose, donor1	10184-103D4	52.19	30.49	36.36	18.77	19.35	2.35	1.17	1.17	0.00	3.52
adipose, donor2	10185-103D5	56.77	42.17	38.12	25.55	10.54	1.22	0.00	0.81	0.00	2.43
adipose, donor3	10186-103D6	55.00	14.16	30.22	16.88	8.44	1.09	1.09	1.63	0.00	3.27
adipose, donor4	10187-103D7	117.88	18.20	18.20	11.27	19.94	1.73	2.60	1.73	0.87	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	55.39	3.00	1.10	1.26	0.63	3.31	0.16	0.16	0.16	0.32
adrenal gland, adult, pool1	10081-102A9	58.20	10.91	0.00	0.00	3.64	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	39.89	0.93	0.40	0.53	0.67	1.20	0.53	0.27	0.13	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	52.17	6.79	1.43	0.71	0.36	0.71	0.36	1.43	1.07	0.00
amniotic membrane cells, donor1	12235-129G3	64.22	6.26	0.70	0.70	0.23	0.23	0.23	0.70	2.09	0.70
amniotic membrane cells, donor2	12236-129G4	57.14	9.47	2.37	1.69	1.69	0.68	0.00	0.34	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	73.36	3.54	0.88	0.29	0.88	2.06	0.29	0.88	0.29	0.29
amygdala - adult, donor10196	10167-103B5	100.79	5.93	1.19	1.19	0.00	1.19	1.19	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	137.88	7.30	1.42	0.81	0.61	3.45	0.81	1.01	0.20	0.00
amygdala, newborn, donor10223	10360-105E9	43.90	4.52	0.65	0.65	0.97	1.29	0.32	0.00	0.00	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	87.09	14.39	2.67	5.35	1.78	2.04	1.66	0.89	0.25	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	82.95	11.47	1.10	1.32	2.21	2.21	1.32	1.99	0.66	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	62.46	5.34	8.02	4.68	1.34	2.34	1.34	1.00	0.00	0.67
aorta, adult, pool1	10052-101G7	75.71	4.51	0.00	0.39	0.98	1.37	1.37	0.59	0.00	0.20
appendix, adult	10189-103D9	59.77	10.87	0.78	1.55	3.10	3.10	0.39	1.55	0.39	1.94
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	38.86	6.53	1.03	1.38	0.69	1.38	1.03	1.03	0.34	0.00
artery, adult	10190-103E1	50.27	9.51	1.36	4.08	5.43	1.36	1.36	2.72	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	26.66	11.30	3.33	2.03	1.30	0.29	1.01	0.14	0.29	0.43
b cell line:RPMI1788	10427-106D4	72.57	5.35	0.89	2.08	1.19	4.16	1.04	0.74	0.00	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	29.41	5.83	1.11	0.28	1.66	0.83	0.55	0.55	0.28	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	49.32	14.98	1.19	1.29	2.78	1.39	0.99	0.69	0.40	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	32.81	3.68	0.33	0.17	1.51	0.50	0.17	0.17	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	58.72	4.47	0.56	0.56	1.68	1.68	1.12	0.00	0.00	0.56
bladder, adult, pool1	10011-101C2	105.16	12.93	1.09	4.13	1.41	0.87	1.09	1.74	0.33	1.30
blood, adult, pool1	10053-101G8	170.53	17.72	0.00	4.43	2.21	4.43	0.00	2.21	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	26.55	9.42	0.00	0.86	0.00	1.71	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	28.34	4.72	0.67	0.67	1.35	0.67	0.67	2.02	0.00	0.00
brain, adult, donor1	10084-102B3	65.60	7.18	1.03	6.15	3.08	0.00	1.03	1.03	0.00	2.05
brain, adult, pool1	10012-101C3	73.50	9.13	3.01	2.45	1.56	1.34	1.34	1.11	0.00	1.00
brain, fetal, pool1	10085-102B4	122.88	0.00	10.69	2.67	0.00	5.34	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	43.28	3.63	0.99	2.31	3.30	0.66	0.00	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	93.87	6.62	1.00	0.50	3.62	1.25	0.25	0.37	0.25	0.25
breast, adult, donor1	10080-102A8	91.55	6.31	1.26	6.31	1.26	6.31	0.63	0.63	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	31.25	5.08	0.25	0.51	1.14	0.76	1.14	0.76	0.00	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	40.82	7.42	0.00	0.31	4.95	1.55	1.55	1.24	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	35.45	3.45	0.23	0.69	0.46	0.46	0.23	0.46	0.23	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	25.18	1.45	0.24	0.24	0.24	0.00	0.00	0.00	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	49.37	1.88	0.00	2.82	0.94	1.88	0.00	0.00	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	102.60	24.72	1.86	2.95	1.53	4.38	0.44	0.44	0.44	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	59.26	2.22	0.63	0.32	0.32	2.85	0.32	1.27	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	67.61	10.38	6.12	6.39	0.80	1.86	0.00	1.33	0.27	0.53
caudate nucleus - adult, donor10196	10177-103C6	90.95	6.91	1.15	1.15	2.30	2.30	0.00	5.76	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	110.27	5.69	2.01	1.67	0.33	3.01	0.50	1.00	0.17	0.33
caudate nucleus, adult, donor10258	10379-105H1	79.47	3.82	0.76	0.76	0.00	0.00	0.76	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	62.26	7.32	3.30	3.66	1.10	1.10	0.37	0.37	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	99.05	0.00	0.00	2.91	2.91	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	144.97	5.76	1.28	3.20	2.14	5.55	1.28	1.28	0.21	1.28
cerebellum, adult, pool1	10083-102B2	60.37	6.90	0.69	3.10	2.07	1.72	0.69	1.03	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	56.46	5.81	2.49	1.66	8.30	1.66	0.00	0.00	0.83	1.66
cerebral meninges, adult	10188-103D8	63.29	6.05	0.76	1.51	1.26	1.51	0.76	0.25	0.50	1.51
cerebrospinal fluid, donor2	10294-104G6	29.97	10.23	1.46	0.00	8.04	0.73	0.00	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	42.99	19.12	0.58	0.43	1.73	1.01	0.58	0.72	0.14	0.43
cervical cancer cell line:ME-180	10553-107I4	77.72	18.39	1.16	0.83	5.80	2.15	0.83	0.50	0.66	0.00
cervix, adult, pool1	10013-101C4	82.10	12.28	2.94	4.93	2.41	1.05	0.52	0.52	0.10	1.89
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	25.08	3.76	0.98	1.11	1.25	0.98	0.56	0.14	0.14	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	47.03	6.53	0.00	0.00	0.00	2.61	0.00	0.00	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	34.42	8.58	0.99	3.36	2.11	0.37	0.50	0.37	0.00	0.50
choriocarcinoma cell line:SCH	10785-110H2	34.75	4.56	0.62	0.86	0.99	0.74	0.37	0.25	0.25	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	43.64	16.60	0.95	3.79	1.90	2.37	1.42	0.47	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	40.74	4.56	0.57	0.57	0.00	1.71	1.14	0.85	0.85	0.57
chorionic membrane cells, donor2	12239-129G7	49.42	9.84	1.49	3.48	2.09	1.39	0.30	0.30	0.20	1.29
chorionic membrane cells, donor3	12240-129G8	53.30	2.75	0.00	1.10	1.10	0.00	0.00	1.10	0.00	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	29.28	14.14	8.08	5.05	0.00	1.01	1.01	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	48.02	4.23	0.96	2.31	1.15	1.34	0.96	0.77	0.19	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	36.54	8.87	1.69	1.06	1.69	1.48	1.27	1.27	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	38.01	6.68	0.51	0.51	0.26	1.03	0.00	1.03	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	43.54	7.98	1.94	0.48	0.24	0.97	0.73	0.00	0.00	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	35.02	7.13	1.43	1.22	0.41	1.02	0.20	0.41	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	25.32	11.78	0.59	0.00	0.59	1.77	0.29	0.59	0.29	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	58.90	4.69	1.56	3.65	0.52	1.82	0.78	0.26	0.00	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	24.92	5.03	0.00	0.46	0.46	0.91	1.60	1.37	0.46	0.23
clear cell carcinoma cell line:TEN	10636-108I6	18.39	5.21	0.35	0.87	1.39	0.00	0.35	0.52	0.00	0.17
colon carcinoma cell line:CACO-2	10513-107D9	26.18	20.32	1.65	2.75	1.83	0.92	1.10	0.00	0.00	0.18
colon carcinoma cell line:COLO-320	10420-106C6	95.78	5.32	1.90	0.76	1.14	2.28	0.38	0.38	0.38	0.38
colon, adult, donor1	10082-102B1	91.63	2.38	1.19	0.00	4.76	1.19	0.00	0.00	0.00	1.19
colon, adult, pool1	10014-101C5	68.97	12.10	1.18	4.58	5.05	0.71	0.59	0.24	1.18	1.41
colon, fetal, donor1	10070-101I7	93.93	6.18	2.47	5.56	1.85	0.62	1.24	2.47	0.62	0.62
common myeloid progenitor CMP, donor1	12130-128D6	192.51	22.92	27.50	13.75	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	12.75	4.25	0.42	1.70	0.85	0.42	0.00	0.00	0.42	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	24.90	6.49	1.66	1.66	3.17	1.36	0.15	0.45	0.00	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	28.06	8.04	2.40	2.54	1.55	0.99	0.42	0.00	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	114.87	24.43	4.98	3.65	2.21	1.88	1.22	0.55	0.33	0.77
cruciate ligament, donor2	10295-104G7	41.33	3.24	0.81	0.00	6.48	0.81	4.05	0.81	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	61.80	19.26	0.80	1.61	1.61	3.21	0.80	3.21	0.00	0.00
diencephalon, adult	10193-103E4	54.00	11.76	4.08	1.92	1.44	0.72	0.48	0.96	0.24	1.20
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	44.77	5.97	1.84	1.38	1.38	1.84	0.69	1.84	0.00	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	63.08	15.39	1.03	2.05	5.13	3.08	0.26	0.26	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	26.96	10.11	1.93	2.41	0.24	1.69	0.24	0.24	0.48	0.24
ductus deferens, adult	10196-103E7	62.79	2.99	0.00	0.50	1.99	0.00	1.00	0.50	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	80.65	10.08	0.00	0.00	7.20	2.88	1.44	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	73.56	12.51	1.47	3.68	3.68	2.21	1.47	3.68	0.74	0.74
dura mater, adult, donor1	10041-101F5	79.53	7.27	3.30	2.89	1.82	0.91	1.57	0.41	0.33	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	22.21	9.10	2.44	3.78	2.22	0.67	1.33	0.44	0.44	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	23.79	8.45	5.16	3.15	0.86	1.00	0.00	0.29	0.14	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	36.38	4.32	0.62	1.23	0.62	1.23	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	31.18	4.54	0.00	0.30	1.21	0.91	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	39.83	7.10	0.62	0.93	0.93	2.47	0.00	0.00	0.31	0.31
embryonic pancreas cell line:2C6	10603-108E9	39.40	3.94	3.94	2.63	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	22.79	17.09	0.34	0.67	1.34	1.01	0.00	0.67	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	44.04	6.34	0.18	0.91	0.00	1.27	0.18	1.45	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	34.41	6.11	0.32	0.32	0.64	0.96	0.64	1.77	0.48	0.32
epidermoid carcinoma cell line:A431	10426-106D3	68.92	6.89	0.67	1.89	2.00	2.11	0.22	0.44	0.89	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	54.55	10.34	1.21	0.77	1.54	2.64	0.88	0.11	0.22	0.11
epididymis, adult	10197-103E8	43.54	7.12	0.84	3.77	3.56	0.84	1.05	0.21	1.05	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	22.35	9.76	0.53	0.71	0.00	0.53	0.35	0.18	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	37.75	14.55	4.72	3.93	0.39	0.79	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	52.03	4.46	0.52	0.66	0.66	1.83	0.39	0.92	0.66	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	76.57	7.38	0.49	0.59	1.28	2.07	0.49	0.79	0.59	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	54.56	5.60	0.56	0.22	0.90	1.68	0.00	0.45	0.34	0.22
esophagus, adult, pool1	10015-101C6	72.84	5.20	1.17	4.03	2.76	0.53	0.74	1.17	0.11	1.59
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	95.81	13.28	6.01	7.39	1.75	1.50	0.75	0.13	0.13	0.25
eye - muscle inferior rectus, donor1	10272-104E2	53.12	21.73	0.00	0.00	12.07	2.41	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	29.46	4.21	0.00	0.00	4.21	2.10	0.00	2.10	2.10	0.00
eye - muscle medial, donor2	10299-104H2	53.58	5.95	2.98	1.49	1.49	1.49	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	32.10	4.59	1.15	1.15	4.59	0.00	1.15	1.15	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	61.21	14.57	1.46	1.46	10.20	0.00	1.46	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	72.71	7.88	2.29	2.03	1.02	1.27	1.27	1.53	0.00	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	45.90	4.23	0.77	1.03	0.90	0.90	0.38	0.38	0.51	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	35.85	6.17	0.71	0.47	1.90	1.66	0.95	0.24	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	77.22	6.10	2.44	1.50	1.03	2.91	1.41	0.28	0.38	0.47
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	78.06	11.41	0.60	1.80	4.20	2.10	1.20	1.20	0.60	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	40.87	7.68	1.10	0.82	0.37	1.10	0.27	0.37	0.27	0.18
gall bladder, adult	10198-103E9	66.88	7.00	1.45	2.90	2.17	0.97	0.72	0.00	0.00	1.93
gamma delta positive T cells, donor1	11937-126A2	53.69	5.91	0.54	0.54	0.54	1.07	1.07	0.54	0.00	1.61
gamma delta positive T cells, donor2	11938-126A3	53.78	4.11	1.12	1.12	1.12	0.00	0.75	0.37	0.00	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	48.58	5.28	0.42	1.48	3.17	2.11	0.00	1.48	0.84	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	39.65	11.02	0.39	0.58	1.16	1.16	0.39	0.58	0.19	0.39
gastric cancer cell line:AZ521	10549-107H9	64.11	9.67	3.28	1.97	1.80	2.13	0.49	0.82	1.15	0.00
gastric cancer cell line:GSS	10560-108A2	43.02	8.24	1.83	0.92	0.92	1.83	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	38.38	8.00	9.37	6.85	1.60	1.14	1.14	0.91	0.23	0.46
giant cell carcinoma cell line:LU65	10487-107B1	57.14	4.82	0.23	0.57	0.69	1.72	0.46	0.57	0.34	0.46
giant cell carcinoma cell line:Lu99B	10433-106E1	97.55	11.20	3.50	2.38	1.12	2.80	0.00	0.14	0.14	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	49.88	11.22	0.25	0.50	3.74	2.24	0.50	0.75	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	41.17	3.91	1.48	0.95	0.32	1.79	0.63	0.42	0.21	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	39.88	3.65	0.84	0.98	1.26	1.12	1.12	0.00	0.42	0.14
glioblastoma cell line:T98G	10485-107A8	33.55	7.84	1.99	0.99	1.77	1.21	0.44	0.22	0.33	0.22
glioma cell line:GI-1	10413-106B8	47.15	12.30	3.81	2.93	2.05	2.34	1.76	0.59	0.00	0.88
globus pallidus - adult, donor10196	10175-103C4	62.69	9.48	0.73	2.19	1.46	2.19	0.00	2.19	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	146.70	10.01	2.69	1.22	1.95	3.17	1.22	1.71	0.49	0.98
globus pallidus, adult, donor10258	10367-105F7	39.71	8.22	1.37	2.74	5.48	0.00	0.00	1.37	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	38.37	6.40	2.66	2.13	1.07	1.07	0.00	1.07	0.53	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	205.56	36.71	9.79	14.68	0.00	12.24	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	10.93	10.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	52.27	5.23	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	41.60	6.72	0.96	0.32	3.52	1.60	0.64	1.92	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	29.38	10.10	4.59	1.84	1.84	2.30	0.92	0.92	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	33.84	9.15	4.57	2.29	1.37	2.29	0.46	1.83	0.46	0.46
hIPS +CCl2, biol_rep3	14385-156C2	21.90	14.17	2.58	3.22	1.29	0.64	0.64	0.64	0.00	0.64
hIPS, biol_rep1	14380-156B6	21.56	15.81	1.44	4.31	2.87	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	30.18	8.92	2.06	0.69	1.37	0.69	0.69	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	48.55	11.03	1.10	2.21	0.00	1.10	0.00	1.10	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	63.22	3.74	2.01	1.72	0.29	4.02	0.00	0.00	0.00	0.29
heart - mitral valve, adult	10205-103F7	59.20	7.18	1.49	1.20	1.79	1.20	0.60	0.60	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	65.37	16.47	1.05	3.14	1.83	1.05	1.05	0.52	0.26	1.05
heart - tricuspid valve, adult	10207-103F9	114.07	5.00	2.50	2.50	1.67	3.33	0.00	0.83	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	64.69	10.20	1.02	1.43	4.08	2.04	1.22	1.63	0.61	0.00
heart, adult, diseased, donor1	10051-101G6	95.81	15.33	0.85	0.85	6.81	2.13	1.28	1.28	0.00	0.85
heart, adult, pool1	10016-101C7	68.53	23.00	2.53	1.38	3.91	1.38	0.23	0.23	0.69	0.69
heart, fetal, pool1	10046-101G1	91.39	18.48	3.90	2.46	1.64	1.95	2.05	0.41	0.51	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	43.50	5.86	0.31	0.00	1.85	1.23	0.62	0.31	0.00	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	36.86	24.97	2.38	2.38	0.00	1.19	0.00	0.00	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	77.46	10.06	8.62	4.20	1.33	1.77	0.66	1.44	0.44	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	79.86	10.44	10.56	3.28	0.97	2.31	0.61	1.09	0.61	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	94.08	9.40	9.80	4.55	1.01	2.73	0.91	0.91	0.40	0.51
hepatoma cell line:Li-7	10484-107A7	29.58	12.34	1.56	0.67	1.00	0.67	0.33	0.22	0.33	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	37.39	5.83	1.41	1.41	0.30	2.21	0.20	0.40	0.10	0.20
hippocampus - adult, donor10196	10169-103B7	74.76	5.68	0.00	0.00	0.95	1.89	0.95	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	135.73	6.74	1.43	1.84	0.61	3.47	0.82	1.43	0.41	0.20
hippocampus, adult, donor10258	10374-105G5	43.82	5.48	1.49	1.00	1.00	2.49	1.00	0.50	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	53.58	4.58	3.52	3.88	1.41	1.76	1.41	0.35	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	39.06	12.21	4.88	6.10	3.66	0.00	1.22	2.44	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	39.86	10.21	6.68	6.87	2.55	1.57	0.39	0.59	0.79	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	43.16	10.16	7.11	5.84	2.29	0.51	0.25	0.76	0.51	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	63.72	30.45	51.88	25.94	21.43	1.69	0.56	0.56	0.56	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	77.46	30.99	70.23	29.69	28.66	1.81	3.61	8.52	0.00	2.84
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	59.60	23.54	48.21	27.71	22.40	1.52	0.38	1.14	0.76	4.18
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	39.71	17.81	28.90	17.23	7.59	0.88	1.17	0.88	0.00	4.67
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	53.00	17.67	40.93	21.76	9.69	1.51	0.43	1.08	0.00	2.59
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	43.38	17.10	37.54	16.68	6.67	1.67	0.00	0.42	0.00	4.59
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	25.81	13.02	31.97	10.66	4.50	0.71	0.71	0.24	0.00	2.60
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	39.38	16.55	34.88	16.23	5.95	0.80	1.29	1.29	0.00	2.57
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	25.59	16.83	39.05	7.41	2.02	1.35	0.00	0.67	0.00	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	37.24	6.73	7.35	5.16	2.19	0.63	0.63	0.78	0.16	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	31.44	4.91	6.88	6.39	2.95	0.98	0.98	4.91	0.98	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	27.06	6.11	1.75	5.24	2.62	1.75	0.87	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	62.05	44.86	84.96	33.60	23.10	1.34	1.15	1.72	0.00	4.01
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	51.89	43.61	75.00	26.60	17.88	1.31	0.00	2.18	0.00	3.92
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	44.48	43.98	60.47	31.98	26.99	1.50	0.00	1.50	0.50	6.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	33.91	33.53	37.49	23.17	12.25	1.32	0.57	0.75	0.00	2.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	35.92	36.38	43.65	22.28	13.64	0.91	0.91	1.36	0.91	3.18
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	36.65	32.26	37.28	19.11	11.59	1.57	0.31	1.25	0.00	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	33.15	19.92	26.29	14.37	10.94	0.82	0.16	0.82	0.33	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	29.03	16.84	23.52	9.58	6.97	1.74	0.87	2.03	0.00	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	37.96	22.72	31.98	13.75	8.67	1.49	0.30	0.30	0.30	2.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	36.76	11.82	9.42	6.65	3.33	1.48	0.74	1.85	0.37	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	46.79	12.84	9.13	5.14	1.71	1.14	0.57	1.43	0.29	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	37.16	19.19	8.98	8.98	1.63	1.63	0.00	0.41	0.82	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	38.73	32.04	46.47	16.90	19.01	1.06	2.11	2.11	0.00	3.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	48.78	31.04	44.03	20.27	19.00	1.27	0.63	0.63	0.95	2.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	57.20	31.47	51.45	28.75	24.51	1.21	0.30	1.21	0.00	5.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	23.79	20.68	26.37	14.48	3.10	1.03	0.00	1.03	0.52	3.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	29.89	19.26	21.25	9.30	4.65	0.66	0.00	0.66	0.00	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	25.65	16.93	21.29	7.18	5.64	0.00	0.00	0.77	0.26	3.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	20.71	15.34	22.24	9.46	6.39	2.30	0.51	1.53	0.00	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	21.96	18.93	26.50	6.82	6.82	0.00	0.00	0.76	0.00	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	31.93	13.78	15.12	7.73	4.70	1.34	0.67	0.34	0.00	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	43.71	13.77	8.69	9.66	2.42	0.97	0.97	0.97	0.24	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	37.44	11.59	9.36	6.68	2.23	1.78	0.45	2.23	0.45	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	41.46	15.12	5.37	8.78	2.44	2.44	0.49	1.95	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	47.07	27.20	63.57	29.64	16.50	1.53	0.61	2.44	0.00	3.06
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	45.55	22.77	29.28	19.52	19.52	3.25	0.00	0.00	3.25	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	38.39	24.82	43.35	21.18	25.48	0.99	0.99	0.66	0.33	3.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	30.65	16.97	35.03	15.87	11.49	0.55	0.55	0.55	0.00	2.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	37.64	10.13	31.12	17.37	3.26	1.09	0.36	0.36	0.36	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	27.76	17.08	30.60	15.30	5.34	0.71	0.36	0.00	0.00	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	25.06	13.13	14.32	9.55	5.97	0.00	0.00	0.00	0.00	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	37.11	16.66	34.67	11.24	7.58	1.08	0.68	1.08	0.27	3.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	35.56	16.97	25.05	11.85	5.12	0.81	0.00	0.54	0.27	1.89
immature langerhans cells, donor1	11904-125F5	25.43	2.18	0.00	0.00	0.48	2.91	1.21	0.48	0.48	0.00
immature langerhans cells, donor2	11905-125F6	30.89	1.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	90.75	5.58	2.84	1.42	2.18	2.84	1.70	0.28	0.38	0.47
keratoacanthoma cell line:HKA-1	10791-110H8	43.57	5.20	0.00	0.65	0.98	0.98	0.00	0.65	0.65	0.00
kidney, adult, pool1	10017-101C8	43.46	12.32	0.80	1.20	3.30	1.50	1.20	0.30	0.20	0.40
kidney, fetal, pool1	10045-101F9	75.62	13.30	6.79	5.31	2.83	2.55	1.34	0.50	0.21	0.85
large cell lung carcinoma cell line:IA-LM	10509-107D5	33.23	32.66	3.55	1.70	0.85	3.27	1.56	0.00	0.28	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	21.70	2.63	0.28	0.14	0.14	1.38	0.00	0.55	0.00	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	39.09	18.35	1.47	0.37	2.57	1.65	0.18	0.00	0.18	0.37
left atrium, adult, donor1	10079-102A7	74.64	9.26	0.54	3.81	2.72	1.09	1.09	1.63	0.00	0.54
left ventricle, adult, donor1	10078-102A6	85.46	12.14	1.01	5.06	3.54	3.54	0.00	0.00	0.51	1.01
leiomyoblastoma cell line:G-402	10721-110A1	55.82	9.03	2.74	3.28	0.00	0.82	0.27	0.27	0.00	0.27
leiomyoma cell line:10964C	10569-108B2	45.98	7.18	1.80	2.51	2.87	1.08	1.08	1.80	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	40.22	5.98	2.17	2.17	2.72	0.54	0.00	1.63	0.00	0.00
leiomyoma cell line:15425	10571-108B4	45.16	6.07	2.19	1.94	2.43	1.70	0.24	3.64	0.24	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	57.14	0.00	0.00	0.00	0.00	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	60.64	14.64	2.09	3.14	2.09	3.14	1.05	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	40.97	4.49	0.71	0.71	0.47	1.77	1.53	0.71	0.12	0.00
liposarcoma cell line:KMLS-1	10782-110G8	24.68	2.81	0.47	0.31	0.47	0.16	0.31	0.00	0.16	0.00
liposarcoma cell line:SW 872	10726-110A6	50.32	14.74	2.56	1.95	1.46	2.07	1.22	0.73	0.12	0.12
liver, adult, pool1	10018-101C9	57.53	8.27	1.30	8.43	4.54	0.49	0.49	0.32	0.49	2.11
liver, fetal, pool1	10086-102B5	54.56	11.29	0.94	0.00	5.64	1.88	0.00	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	80.79	8.17	1.75	2.92	2.48	4.81	0.73	0.73	0.29	0.44
locus coeruleus, adult, donor10252	10165-103B3	94.67	8.12	0.74	1.48	1.11	2.58	0.74	1.29	0.18	0.18
locus coeruleus, adult, donor10258	10375-105G6	36.40	7.05	1.97	0.85	1.13	1.41	0.85	1.97	0.28	0.00
locus coeruleus, newborn, donor10223	10362-105F2	34.07	7.57	0.00	1.68	2.10	1.68	0.42	1.26	0.00	0.84
lung adenocarcinoma cell line:A549	10499-107C4	30.31	13.42	1.52	0.97	0.28	1.38	1.11	0.28	0.14	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	26.89	6.89	0.00	0.00	0.00	1.38	0.00	0.00	2.76	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	73.82	18.45	0.53	2.64	2.77	1.98	0.66	0.40	0.53	0.13
lung, adult, pool1	10019-101D1	76.07	10.75	1.42	4.02	1.42	2.48	0.47	0.24	0.47	1.65
lung, fetal, donor1	10068-101I5	63.65	24.83	1.43	3.71	2.85	1.14	1.14	1.14	0.29	0.57
lung, right lower lobe, adult, donor1	10075-102A3	65.98	7.79	0.92	5.96	3.67	3.67	1.83	0.46	0.46	0.92
lymph node, adult, donor1	10077-102A5	62.48	9.47	1.42	2.84	3.79	0.95	1.42	0.00	0.47	1.42
lymphangiectasia cell line:DS-1	10727-110A7	39.89	6.58	0.66	1.32	1.75	1.53	2.19	0.44	0.00	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	46.49	9.36	1.21	2.26	0.75	1.96	0.91	0.30	0.00	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	23.79	6.80	0.85	0.85	1.70	0.85	0.00	0.00	1.70	0.85
mature adipocyte, donor1	12231-129F8	62.16	11.99	1.78	0.00	3.55	1.33	0.00	0.44	0.44	1.78
mature adipocyte, donor2	12232-129F9	61.01	7.47	0.62	1.04	1.45	0.62	1.04	0.42	0.00	1.04
mature adipocyte, donor3	12233-129G1	64.96	6.64	0.47	1.19	0.71	1.66	0.00	0.24	0.71	0.00
mature adipocyte, donor4	12234-129G2	63.96	17.11	0.79	2.63	0.79	1.05	0.26	0.79	0.26	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	68.62	12.63	1.19	1.67	3.81	4.05	0.48	0.24	0.95	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	63.17	3.38	1.13	1.13	0.00	4.51	1.13	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	120.46	8.09	1.29	1.47	2.39	4.05	2.02	1.47	0.00	1.47
medial frontal gyrus, adult, donor10258	10368-105F8	44.16	4.13	0.64	1.27	0.95	1.59	0.64	0.64	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	50.75	4.69	0.43	1.71	0.00	0.85	1.28	1.28	0.00	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	92.81	4.22	1.69	1.52	0.84	2.03	3.38	9.96	0.17	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	140.70	7.85	0.85	2.12	1.70	4.46	1.91	1.06	0.42	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	23.12	1.93	0.00	0.00	0.00	1.93	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	100.48	0.00	0.00	0.00	0.00	14.35	0.00	28.71	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	57.43	5.38	1.44	1.44	1.79	1.08	0.00	0.36	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	49.97	6.49	0.65	0.65	1.95	4.54	1.30	2.60	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	101.24	8.51	0.77	1.55	1.24	3.25	1.24	1.55	0.00	0.46
medulla oblongata, adult, pool1	10038-101F2	74.53	10.61	3.35	2.37	2.12	3.02	0.98	0.41	0.08	0.41
medulla oblongata, newborn, donor10223	10361-105F1	47.22	6.94	2.08	1.39	1.74	2.43	0.00	0.69	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	67.09	7.75	3.76	4.87	1.33	2.66	0.89	1.55	0.00	0.44
medulloblastoma cell line:ONS-76	10759-110E3	46.71	10.52	1.47	0.61	1.22	2.20	0.37	0.37	0.00	0.49
melanoma cell line:COLO 679	10514-107E1	25.16	9.77	0.57	1.15	1.58	1.01	0.86	0.14	0.00	0.29
melanoma cell line:G-361	10465-106H6	20.36	5.70	0.54	1.36	1.09	0.27	0.00	0.00	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	58.07	7.60	0.72	0.72	0.36	0.90	1.09	2.35	0.36	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	90.76	2.64	9.69	7.05	0.88	1.76	0.88	1.76	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	117.17	16.85	22.29	10.37	1.04	3.11	1.30	2.85	0.00	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	34.68	3.84	0.92	1.23	0.61	0.31	0.15	0.92	0.31	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	38.36	5.27	1.09	0.91	0.36	1.09	0.73	1.09	0.18	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	26.09	6.21	0.00	2.07	0.83	0.83	0.41	1.66	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	36.80	2.53	0.70	0.56	0.56	1.12	0.56	0.28	0.14	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	39.28	3.66	0.96	0.39	0.96	0.58	0.39	0.77	0.39	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	27.07	7.63	0.00	0.69	4.16	1.39	0.00	1.39	0.00	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	40.68	3.26	0.00	1.72	1.03	0.34	0.69	0.17	0.17	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	43.02	3.11	0.58	1.04	0.81	0.69	0.35	0.92	0.23	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	32.89	3.58	1.46	0.80	0.66	0.93	0.93	0.53	0.40	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	26.60	3.38	0.68	0.54	1.08	0.95	0.41	0.54	0.14	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	35.85	4.98	0.57	0.85	1.42	0.43	0.85	0.85	0.14	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	24.70	6.26	0.66	0.99	0.99	0.66	0.33	0.00	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	34.59	2.91	1.11	0.69	0.83	0.69	0.14	0.97	0.00	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	31.77	4.19	0.70	0.35	2.44	1.40	0.70	1.05	0.35	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	35.93	3.47	0.82	0.82	0.41	0.82	0.41	0.41	0.00	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	26.60	6.83	0.72	1.80	1.08	0.36	0.00	0.36	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	36.31	3.21	0.10	0.72	0.31	0.93	0.52	0.93	0.21	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	20.75	2.28	0.23	0.91	0.68	0.23	0.68	0.46	0.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	22.66	5.87	0.84	0.84	0.84	1.26	1.26	0.42	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	30.19	2.84	0.75	0.45	1.20	0.45	0.45	0.45	0.15	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	33.61	3.68	0.44	0.53	0.79	1.49	0.61	1.05	0.26	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	38.29	1.84	0.37	0.74	0.74	2.21	0.00	1.10	1.10	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	25.47	6.01	2.00	0.57	2.29	0.29	1.72	0.86	0.29	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	31.58	8.42	1.68	2.11	0.42	0.84	2.11	0.84	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	28.31	5.94	1.37	1.37	2.28	0.46	0.46	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	28.14	6.14	0.26	1.53	1.79	1.02	0.51	0.26	0.51	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	38.22	4.19	0.79	1.57	1.31	1.83	2.09	0.52	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	36.97	6.16	1.54	1.23	2.16	0.62	0.62	1.23	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	35.30	6.35	2.12	2.59	0.94	1.41	0.24	0.71	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	34.52	4.06	0.34	0.68	0.68	0.68	0.68	0.34	0.00	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	29.47	6.29	1.18	1.96	1.18	0.39	0.39	0.00	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	27.34	6.49	0.46	1.85	2.78	1.39	0.46	1.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	37.21	8.36	0.87	1.44	2.02	0.29	0.29	0.29	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	42.61	5.58	0.22	1.12	1.12	0.67	0.45	0.00	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	36.77	5.77	1.68	1.44	0.72	0.72	0.48	0.96	0.48	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	44.73	11.73	1.47	2.20	2.20	0.73	0.00	2.93	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	29.87	2.01	1.01	1.01	1.68	0.34	0.34	0.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	24.56	4.09	1.23	1.23	2.46	0.82	1.23	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	34.36	6.01	0.43	0.86	1.29	0.86	1.72	0.86	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	46.48	2.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	18.84	3.90	0.97	1.95	3.57	0.00	1.30	0.65	0.00	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	18.91	2.91	1.45	1.45	1.45	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	19.72	4.80	1.60	0.00	2.13	0.53	0.00	1.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	16.36	5.72	0.00	0.82	0.82	0.82	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	24.88	6.61	0.39	1.17	2.33	0.39	1.94	1.17	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	20.99	4.20	0.00	0.00	4.20	0.00	0.00	6.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	15.90	7.95	0.00	0.99	1.99	0.00	0.00	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	9.53	0.00	0.00	0.00	0.00	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	19.57	2.37	0.00	1.78	3.56	0.00	0.59	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	19.50	1.22	0.00	0.00	0.00	1.22	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	18.37	5.70	0.63	1.90	1.90	0.63	0.63	0.00	1.27	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	22.42	3.45	0.34	0.69	1.38	0.69	0.00	0.69	1.38	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	2.15	0.00	2.15	0.00	0.00	0.00	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	3.99	0.00	0.00	0.00	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	37.88	0.00	0.00	0.00	3.44	0.00	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	31.38	3.67	0.41	0.41	0.81	0.81	0.81	0.81	0.81	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	44.49	5.56	0.00	1.59	0.79	0.00	0.00	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	34.78	4.13	1.18	0.59	0.00	0.59	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	30.55	4.05	0.31	0.62	2.18	0.31	0.31	0.62	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	41.44	1.34	0.00	1.34	0.00	0.00	2.67	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	36.66	8.28	1.18	0.00	0.00	0.00	0.00	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	25.68	0.00	2.57	2.57	2.57	0.00	5.14	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	25.47	4.82	0.69	1.38	2.75	0.69	0.00	0.69	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	27.21	9.40	0.00	1.48	0.99	1.48	0.49	0.00	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	22.43	7.85	2.24	0.00	2.24	0.00	0.00	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	24.17	7.00	1.91	0.64	3.18	0.64	0.64	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	34.25	7.25	1.21	0.81	1.61	1.21	0.81	1.21	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	28.35	4.36	0.00	0.00	4.36	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	25.34	5.07	2.53	0.00	2.53	0.00	0.00	2.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	30.95	10.32	0.00	1.82	4.25	0.61	1.21	1.21	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	9.04	0.00	0.00	4.52	0.00	4.52	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	39.54	10.71	0.82	0.82	1.65	0.82	0.00	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	27.98	8.93	0.99	0.40	1.39	0.40	0.60	0.20	0.00	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	25.31	10.06	0.65	0.97	1.95	0.00	0.65	0.65	0.00	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	28.52	10.19	0.00	1.02	3.06	0.00	0.00	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	68.86	20.89	0.00	1.55	1.55	1.55	0.00	0.00	1.55	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	51.97	7.80	0.47	0.24	0.47	1.42	0.24	0.47	0.47	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	46.33	3.94	2.32	1.39	2.32	1.39	1.62	0.46	0.93	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	81.20	4.27	0.00	4.27	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	27.95	5.45	0.51	0.92	1.85	0.82	0.72	0.72	0.21	0.51
mesothelioma cell line:Mero-25	10850-111F4	26.55	9.53	2.04	2.95	0.45	0.68	0.68	0.45	0.00	0.23
mesothelioma cell line:Mero-41	10851-111F5	56.96	5.87	0.24	0.24	1.47	2.20	0.24	0.98	0.24	0.98
mesothelioma cell line:Mero-48a	10852-111F6	78.83	20.81	1.55	1.55	3.10	2.88	1.33	0.89	1.11	1.55
mesothelioma cell line:Mero-82	10853-111F7	45.47	11.56	1.05	2.37	0.79	0.79	1.05	1.31	0.26	0.26
mesothelioma cell line:Mero-83	10854-111F8	67.41	7.66	1.02	2.55	1.53	1.87	0.17	0.85	0.85	0.34
mesothelioma cell line:Mero-84	10855-111F9	24.77	5.56	0.76	0.51	0.76	0.25	0.25	0.25	0.51	0.00
mesothelioma cell line:Mero-95	10856-111G1	36.03	8.90	0.21	1.86	1.86	1.66	0.62	0.62	0.41	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	49.53	12.09	1.16	1.49	2.32	0.99	0.50	0.33	0.33	0.50
mesothelioma cell line:NCI-H226	10846-111E9	18.46	2.53	1.45	1.27	0.54	0.54	0.36	0.36	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	24.43	2.73	0.17	0.68	0.17	0.51	0.17	0.51	0.17	0.00
mesothelioma cell line:NCI-H28	10845-111E8	39.44	4.83	0.76	1.78	1.02	1.78	0.51	0.51	0.51	1.02
mesothelioma cell line:No36	10857-111G2	36.21	6.20	0.98	1.30	0.00	0.98	0.33	1.30	0.65	0.00
mesothelioma cell line:ONE58	10858-111G3	24.11	3.79	0.00	0.00	1.35	1.08	0.00	0.27	0.27	0.27
migratory langerhans cells, donor1	11901-125F2	27.25	2.11	0.19	0.58	0.96	0.77	1.15	0.00	0.00	0.38
migratory langerhans cells, donor2	11902-125F3	20.03	3.91	0.37	0.37	0.98	0.85	0.37	0.37	0.12	0.37
migratory langerhans cells, donor3	11903-125F4	30.51	3.59	0.36	0.72	0.36	1.62	1.62	0.18	0.36	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	31.67	2.29	0.33	0.65	0.65	1.63	0.98	0.98	0.00	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	30.52	4.66	0.64	0.21	0.64	1.48	0.64	1.06	0.21	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	40.54	13.13	0.69	0.46	3.46	1.15	0.23	0.00	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	39.39	9.90	1.14	1.52	2.28	0.57	0.57	0.00	0.00	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	39.92	14.41	0.37	1.29	0.37	1.29	1.11	0.74	0.18	0.00
myeloma cell line:PCM6	10474-106I6	17.20	17.59	0.40	0.99	2.77	0.00	0.40	0.40	0.00	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	39.57	4.06	0.51	0.00	3.55	1.01	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	38.44	1.96	0.59	0.59	1.37	0.98	0.20	0.39	0.00	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	28.41	1.34	0.00	0.11	0.33	0.89	0.00	0.22	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	25.59	1.47	0.22	0.07	0.00	1.69	0.00	0.37	0.00	0.07
nasal epithelial cells, donor2	12227-129F4	54.09	4.97	0.00	0.00	1.10	1.10	0.00	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	46.93	25.54	37.27	15.64	1.38	3.22	2.53	0.23	0.00	1.38
neuroblastoma cell line:NB-1	10539-107G8	63.80	25.82	11.79	3.37	1.31	4.30	1.68	0.19	0.56	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	31.21	4.01	2.32	1.05	0.21	1.48	0.00	0.63	0.42	0.00
neuroblastoma cell line:NH-12	10555-107I6	81.06	8.57	14.54	10.62	0.75	2.98	0.56	0.56	0.19	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	65.95	2.37	1.66	6.17	0.24	1.19	0.24	2.14	0.24	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	58.13	2.53	2.22	5.07	1.74	1.43	0.16	0.95	0.16	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	50.52	4.23	3.42	4.23	0.00	1.81	0.60	0.60	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	96.64	5.72	5.09	6.36	0.00	5.09	0.00	1.27	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	44.72	8.25	0.80	0.53	2.66	0.80	0.00	0.53	0.00	0.53
neutrophil PMN, donor1	12133-128D9	297.50	178.50	0.00	0.00	0.00	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	79.68	13.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	85.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	87.94	21.14	9.64	8.46	0.34	1.86	0.34	0.00	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	48.83	25.62	1.60	0.80	3.20	2.40	0.80	0.00	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	44.56	9.62	1.28	1.28	1.60	0.64	1.28	0.32	0.00	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	33.90	5.26	1.58	0.53	2.63	0.79	0.53	0.79	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	85.02	7.12	2.81	1.97	1.69	2.91	1.03	0.56	0.28	1.03
occipital cortex - adult, donor10196	10172-103C1	67.99	2.06	0.00	2.06	2.06	4.12	2.06	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	175.78	10.20	1.88	0.81	1.34	3.76	2.68	1.34	0.27	0.54
occipital cortex, newborn, donor10223	10355-105E4	59.32	4.37	2.18	2.18	1.09	1.09	0.73	0.36	0.00	0.73
occipital lobe, adult, donor1	10076-102A4	50.91	6.30	1.84	2.89	3.67	2.36	1.84	0.52	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	90.11	12.87	9.44	8.58	1.29	3.00	3.86	2.57	0.00	0.43
occipital pole, adult, pool1	10036-101E9	82.31	8.12	1.97	2.13	1.26	2.84	0.55	0.32	0.47	0.39
olfactory region, adult	10195-103E6	76.61	6.50	2.29	2.67	1.53	2.67	0.38	0.57	0.96	1.34
optic nerve, donor1	10277-104E7	104.05	30.02	2.00	6.00	14.01	0.00	0.00	0.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	46.70	5.13	0.46	2.05	0.46	0.57	0.34	0.23	0.23	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	46.57	2.75	1.79	0.55	0.41	2.34	0.27	0.14	0.00	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	46.06	13.38	0.68	1.52	2.20	1.19	1.35	2.88	0.51	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	52.09	12.59	0.69	1.96	2.77	2.08	0.35	0.69	0.35	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	46.74	7.06	0.88	0.59	0.88	0.88	0.29	0.59	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	43.91	28.96	4.67	1.87	4.67	1.87	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	34.35	4.45	1.48	1.70	0.64	0.42	0.42	0.42	0.21	0.21
ovary, adult, pool1	10020-101D2	57.39	14.33	4.45	4.28	0.87	0.79	1.83	0.44	0.17	1.48
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	26.58	5.50	0.73	0.37	0.18	3.30	0.37	0.55	0.00	0.37
pancreas, adult, donor1	10049-101G4	100.65	21.63	2.82	1.88	5.64	0.94	0.00	3.76	1.88	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	40.81	8.39	1.12	3.07	1.12	0.28	1.68	0.84	0.28	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	42.59	18.06	1.36	0.51	1.19	0.34	1.87	2.90	0.17	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	81.14	20.04	0.99	1.99	3.31	2.48	0.66	0.17	0.50	0.17
paracentral gyrus, adult, pool1	10035-101E8	80.17	7.60	2.75	2.20	1.37	2.20	0.73	0.09	0.46	0.73
parietal cortex, adult, donor10258	10373-105G4	60.19	5.87	5.87	2.94	0.73	3.67	0.73	1.47	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	57.37	2.82	0.00	0.00	2.82	3.76	2.82	1.88	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	113.73	5.13	0.86	0.86	0.57	2.28	1.14	1.71	0.57	0.57
parietal lobe, adult, pool1	10034-101E7	86.45	5.73	2.11	1.41	1.41	3.26	0.53	0.53	0.70	0.35
parietal lobe, fetal, donor1	10072-101I9	92.13	9.70	16.49	9.70	1.94	2.91	1.94	4.85	0.00	2.91
parietal lobe, newborn, donor10223	10356-105E5	48.98	5.98	1.12	1.12	1.87	0.75	0.37	0.00	0.37	0.37
parotid gland, adult	10199-103F1	37.62	3.08	0.00	0.62	0.62	1.23	0.00	1.23	0.62	1.23
penis, adult	10200-103F2	62.31	10.74	0.54	3.76	3.76	1.61	1.07	2.69	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	34.58	1.67	0.19	1.12	0.00	0.56	0.19	0.56	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	42.54	13.55	0.73	1.02	4.08	1.60	1.02	0.87	0.58	0.29
pineal gland - adult, donor10196	10179-103C8	58.05	3.23	0.00	1.94	0.00	2.58	0.65	1.94	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	102.45	8.88	0.00	0.59	1.78	1.78	2.96	0.00	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	51.42	4.39	0.63	1.25	1.25	1.88	0.00	0.63	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	44.52	14.17	0.00	0.00	1.01	4.05	1.01	0.00	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	86.52	8.86	0.00	2.61	0.00	2.61	2.08	0.00	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	40.86	4.26	0.85	0.85	0.85	1.70	2.55	0.00	0.00	0.85
placenta, adult, pool1	10021-101D3	58.27	8.82	0.86	2.26	1.72	0.75	0.65	0.32	0.32	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	40.66	6.22	0.40	1.32	0.53	1.72	0.79	0.79	0.00	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	62.88	7.47	0.78	1.40	1.87	2.49	1.09	0.47	0.47	0.47
pons, adult, pool1	10033-101E6	53.79	8.00	2.41	1.55	2.24	3.10	0.86	0.60	0.52	0.43
postcentral gyrus, adult, pool1	10032-101E5	78.37	7.15	2.18	1.83	1.48	2.44	0.87	0.70	0.35	0.70
promyelocytes/myelocytes PMC, donor1	12132-128D8	106.66	18.82	4.18	4.18	2.09	2.09	0.00	0.00	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	56.08	9.18	1.31	1.17	1.31	1.46	0.73	0.73	0.29	0.15
prostate cancer cell line:PC-3	10439-106E7	44.29	10.89	0.36	0.18	0.73	1.27	0.18	0.18	0.73	0.36
prostate, adult, pool1	10022-101D4	66.48	9.98	0.82	2.09	1.54	1.72	0.73	0.00	0.09	1.09
putamen, adult, donor10196	10176-103C5	124.41	4.49	2.36	1.89	0.94	2.12	0.47	1.18	0.24	0.47
putamen, adult, donor10252	10152-102I8	68.63	7.84	1.96	1.96	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	34.97	4.37	1.09	2.19	1.09	0.00	0.00	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	85.53	6.04	2.17	3.14	0.00	2.17	0.00	0.72	0.00	0.48
putamen, newborn, donor10223	10365-105F5	50.23	3.00	1.50	0.00	0.75	2.25	0.75	3.75	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	56.44	24.15	0.58	0.29	4.95	2.33	0.58	0.29	0.29	0.00
rectum, fetal, donor1	10067-101I4	57.03	11.13	6.95	1.39	11.13	0.00	8.35	2.78	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	22.47	3.82	0.85	0.42	0.85	0.21	0.85	0.42	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	19.47	0.83	0.00	0.00	0.00	0.41	0.00	0.41	0.00	0.00
retina, adult, pool1	10030-101E3	75.64	10.24	1.29	1.79	2.78	1.89	2.88	0.30	0.99	0.70
retinoblastoma cell line:Y79	10475-106I7	46.50	3.12	4.16	3.12	0.26	1.56	0.52	0.00	0.00	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	41.68	2.09	3.69	3.07	0.37	0.98	0.37	0.49	0.37	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	67.49	36.27	10.97	5.62	1.69	2.53	0.28	0.56	0.56	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	85.64	19.70	4.55	3.79	3.03	0.76	0.00	1.52	1.52	0.76
salivary acinar cells, donor1	11771-123I7	41.44	3.88	0.81	1.78	1.46	0.65	0.49	0.16	0.00	0.00
salivary acinar cells, donor2	11772-123I8	39.79	9.36	0.55	4.27	1.24	0.28	0.28	0.69	0.14	0.96
salivary acinar cells, donor3	11773-123I9	86.73	29.79	0.00	1.32	4.63	1.32	0.00	0.00	0.66	0.00
salivary gland, adult, pool1	10093-102C3	35.46	3.43	0.57	0.57	2.29	0.00	0.57	0.00	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	51.26	10.12	1.01	1.60	0.93	1.85	0.59	0.51	0.08	0.59
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	43.38	11.52	1.76	1.53	0.35	2.00	0.59	0.35	0.12	0.35
seminal vesicle, adult	10201-103F3	33.86	4.23	0.00	0.00	2.65	0.00	1.06	0.00	0.00	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	29.39	4.13	0.73	1.21	1.46	0.49	0.24	1.46	0.73	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	56.11	7.30	1.01	1.76	2.01	2.01	1.01	1.26	1.01	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	50.18	13.05	0.00	0.00	1.00	2.01	0.00	0.00	1.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	30.89	10.88	1.75	1.07	0.54	1.07	0.40	0.27	0.00	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	53.72	9.51	1.44	1.77	2.76	2.76	0.66	0.33	0.22	0.66
signet ring carcinoma cell line:NUGC-4	10483-107A6	77.67	12.77	0.77	0.77	2.84	1.42	1.29	0.52	0.00	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	26.25	13.48	0.00	0.71	7.09	2.84	2.13	0.71	0.71	1.42
skeletal muscle, adult, pool1	10023-101D5	89.23	24.83	4.32	8.16	5.04	1.68	1.32	0.84	0.48	1.68
skeletal muscle, fetal, donor1	10066-101I3	44.22	16.08	2.01	5.03	0.00	0.00	1.01	6.03	0.00	0.00
skin, adult, donor1	10074-102A2	101.78	0.00	0.00	20.36	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	27.77	8.21	1.26	1.26	5.68	1.89	2.52	2.52	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	72.71	9.34	1.67	1.33	1.33	3.34	1.33	1.00	1.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	89.52	13.24	6.93	6.93	2.52	2.21	2.21	2.84	1.26	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	43.95	6.55	2.31	3.08	1.54	2.31	0.77	0.58	0.19	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	61.81	10.05	0.99	1.15	1.65	3.46	1.32	0.33	0.00	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	50.02	2.90	2.90	2.73	0.64	3.86	0.16	0.80	0.16	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	56.22	27.02	1.96	2.40	5.45	1.74	1.53	0.00	0.87	0.22
small intestine, adult, pool1	10024-101D6	96.75	8.84	0.96	5.73	8.96	1.43	0.84	0.36	2.03	2.27
small intestine, fetal, donor1	10064-101I1	69.78	7.62	1.47	1.47	2.46	2.21	1.97	2.70	2.70	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	31.29	3.08	1.54	0.00	2.05	0.00	1.03	0.51	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	79.60	8.27	1.29	1.03	1.55	2.07	1.55	0.52	0.00	0.52
somatostatinoma cell line:QGP-1	10781-110G7	86.84	11.52	0.00	0.54	1.88	1.34	0.27	0.27	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	93.83	7.11	1.38	1.61	2.06	2.29	3.90	4.82	0.00	0.00
spinal cord, adult, donor10252	10159-103A6	115.52	9.86	1.18	2.37	0.79	3.94	1.58	0.39	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	22.83	4.15	1.38	1.38	0.69	2.08	2.77	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	48.18	8.54	3.05	3.05	3.05	3.05	2.44	2.44	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	39.95	7.35	1.38	0.46	0.00	0.46	0.92	0.92	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	40.03	7.92	0.75	0.30	2.09	1.05	0.60	0.30	0.15	0.60
spleen, adult, pool1	10025-101D7	60.02	11.45	1.54	2.86	1.98	1.10	1.43	0.44	0.66	1.10
spleen, fetal, pool1	10044-101F8	66.35	10.17	1.99	2.46	5.09	1.99	2.30	0.79	0.48	0.64
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	41.09	4.14	0.21	0.72	0.72	1.45	0.31	0.72	0.00	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	81.27	11.77	0.95	0.57	1.14	2.66	0.57	0.19	0.19	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	51.72	12.58	1.75	0.70	2.10	2.10	1.05	1.05	0.35	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	31.27	10.95	0.78	0.00	2.35	1.56	0.39	0.78	0.39	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	43.11	25.78	1.58	1.13	4.16	1.24	1.80	0.79	0.11	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	81.33	13.98	1.27	1.27	2.54	0.85	0.85	2.12	0.85	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	68.54	11.42	0.42	1.69	2.12	1.69	1.27	0.42	0.42	0.00
stomach, fetal, donor1	10062-101H8	73.69	12.82	0.00	0.00	6.41	0.00	0.00	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	26.21	5.13	0.57	0.57	1.14	0.00	0.00	1.71	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	127.53	12.67	1.04	2.28	1.87	2.08	0.42	1.87	0.42	0.83
substantia nigra, adult, donor10258	10371-105G2	30.52	6.21	0.52	0.52	0.52	2.59	0.00	0.00	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	44.51	2.12	1.41	2.12	2.12	0.71	0.71	1.41	0.00	2.12
synovial sarcoma cell line:HS-SY-II	10441-106E9	60.98	8.71	1.38	2.29	1.38	2.52	0.92	0.92	0.23	0.23
temporal lobe, adult, pool1	10031-101E4	84.35	9.49	2.63	3.14	2.03	1.61	1.10	0.34	0.34	0.51
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	64.82	8.55	8.55	11.40	0.00	2.14	4.27	4.27	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	71.21	10.99	5.27	8.35	0.44	2.20	2.64	2.64	0.44	0.88
tenocyte, donor1	11763-123H8	54.11	5.24	1.05	0.35	1.75	1.40	0.70	2.09	0.35	0.35
tenocyte, donor2	11765-123I1	58.75	4.58	0.00	1.14	0.38	0.38	1.14	0.76	0.76	0.00
tenocyte, donor3	11768-123I4	54.12	5.19	0.37	0.00	1.48	1.11	0.37	0.37	1.11	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	47.08	19.04	12.07	8.33	1.53	2.04	0.34	0.68	0.51	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	72.91	8.48	7.40	9.56	2.31	3.24	0.62	0.31	0.00	0.46
teratocarcinoma cell line:PA-1	10807-111A6	28.21	15.81	23.71	11.00	1.39	2.01	0.77	0.62	0.15	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	27.80	13.46	3.55	5.20	1.65	1.14	0.00	0.25	0.13	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	29.88	14.75	1.89	4.92	0.00	1.89	0.38	0.00	0.76	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	28.57	39.26	0.98	3.60	2.18	0.98	0.33	0.55	0.33	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	28.66	12.05	3.58	2.61	0.65	1.30	0.33	0.98	0.00	0.33
testis, adult, pool1	10026-101D8	73.23	14.39	37.26	19.86	2.25	6.55	0.97	1.72	0.64	10.52
testis, adult, pool2	10096-102C6	86.16	12.18	54.58	8.57	6.32	9.02	0.90	2.71	3.16	2.26
thalamus - adult, donor10196	10168-103B6	68.45	13.25	2.21	3.31	0.00	3.31	1.10	1.10	0.00	0.00
thalamus, adult, donor10252	10154-103A1	130.34	16.57	2.50	1.09	1.25	1.88	0.31	1.25	0.31	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	30.79	13.86	0.00	3.08	1.54	1.54	1.54	0.00	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	38.37	5.27	1.81	1.65	1.32	0.49	0.66	0.66	0.00	0.00
thalamus, newborn, donor10223	10366-105F6	31.07	3.45	0.58	1.15	1.73	1.73	1.15	1.73	0.00	1.15
throat, adult	10209-103G2	34.95	11.24	2.25	1.75	4.74	1.50	0.50	0.50	0.25	0.50
throat, fetal, donor1	10061-101H7	54.54	12.80	1.83	2.44	0.91	0.61	4.88	2.13	0.00	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	66.97	2.19	3.97	8.15	0.40	2.38	0.40	0.40	0.00	0.00
thymus, adult, pool1	10027-101D9	102.50	16.30	6.36	16.11	1.79	2.88	1.09	0.99	0.10	2.29
thymus, fetal, pool1	10043-101F7	108.58	13.09	3.53	7.69	3.84	3.53	0.52	0.62	0.31	1.45
thyroid carcinoma cell line:KHM-5M	10776-110G2	23.00	8.11	0.80	0.53	1.06	0.66	0.80	0.40	0.27	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	57.27	10.34	2.65	0.70	1.96	1.68	3.63	1.12	0.14	0.14
thyroid, adult, pool1	10028-101E1	58.79	10.08	1.21	1.68	2.05	1.49	1.40	0.37	0.19	0.84
thyroid, fetal, donor1	10060-101H6	59.85	10.81	1.32	2.11	2.11	2.11	1.05	1.05	0.26	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	9.24	3.08	6.16	3.08	12.32	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	51.86	13.72	1.86	2.56	3.72	0.93	0.70	0.93	0.70	1.16
tongue, fetal, donor1	10059-101H5	85.91	17.34	2.76	3.15	1.97	0.79	3.15	3.15	0.39	0.39
tonsil, adult, pool1	10047-101G2	72.83	6.41	0.60	1.40	4.51	2.60	1.30	0.70	0.10	0.30
trachea, adult, pool1	10029-101E2	51.04	6.79	1.06	1.23	2.29	0.82	0.65	0.49	0.49	0.90
trachea, fetal, donor1	10058-101H4	55.40	15.39	2.31	3.46	0.77	0.38	1.15	1.15	0.38	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	56.33	12.75	3.54	1.77	2.83	2.83	0.35	0.35	0.00	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	58.86	15.81	4.46	1.72	2.03	2.33	0.91	0.30	0.81	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	35.41	8.77	0.16	1.88	2.66	1.72	0.78	0.16	0.31	0.63
tridermal teratoma cell line:HGRT	10694-109G1	91.32	13.32	1.90	1.90	5.71	1.90	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	56.21	14.14	1.19	2.03	3.47	2.12	1.19	0.42	0.25	0.51
umbilical cord, fetal, donor1	10057-101H3	52.16	12.52	0.00	0.00	4.17	0.00	0.00	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	85.66	12.63	2.90	2.56	3.75	1.88	1.37	0.34	0.68	0.34
uterus, fetal, donor1	10055-101H1	65.01	13.31	3.58	6.14	4.10	3.07	3.07	1.02	0.51	0.51
vagina, adult	10204-103F6	91.76	6.46	0.00	3.88	1.29	0.65	0.00	0.65	0.00	0.65
vein, adult	10191-103E2	48.88	7.23	1.10	2.85	2.85	1.53	0.44	0.44	0.44	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	56.88	5.87	0.27	0.80	0.53	1.07	0.27	0.27	0.27	0.27